212 results on '"Min, Ren"'
Search Results
2. KCNQ1OT1 affects cell proliferation, invasion, and migration through a miR-34a / Notch3 axis in breast cancer
- Author
-
Zhiyao Ren, Yunfeng Xu, Xin Wang, and Min Ren
- Subjects
Health, Toxicology and Mutagenesis ,Breast Neoplasms ,General Medicine ,Pollution ,Gene Expression Regulation, Neoplastic ,MicroRNAs ,Potassium Channels, Voltage-Gated ,Cell Line, Tumor ,Humans ,Environmental Chemistry ,Female ,RNA, Long Noncoding ,Receptor, Notch3 ,Cell Proliferation - Abstract
Breast cancer (BC) accounts for a significant share of cancer-related deaths worldwide. Ongoing investigations have shown that long non-coding RNAs (lncRNAs) drive BC progression but their underlying mechanisms remain largely undescribed. LncRNA KCNQ1OT1 was previously identified in BC but its functional significance remained to be fully investigated.KCNQ1OT1 and its downstream target genes were analyzed in breast cancer tissues and cell lines using methods including RT-qPCR, immunohistochemistry and Western blotting. The effects of KCNQ1OT1, miR-34a and Notch3 on BC cells were investigated using assays measuring proliferation (CCK-8, colony formation), apoptosis, and migration/invasion (scratch and Transwell assays). MS2-RIP and dual-luciferase reporter assays were used to study RNA interactions. Xenograft studies were employed to define the tumorigenic potential of KCNQ1OT1 in vivo.KCNQ1OT1 expression was up-regulated in BC tissues and high levels were associated with poorer prognosis. ShRNA inhibition of KCNQ1OT1 expression in BC cell lines retarded proliferation, migration and invasion in vitro and tumor growth in vivo. Up-regulation of KCNQ1OT1 was shown to inhibit miR-34a which was associated with blocking the inhibitory effect of miR-34a on BC cell proliferation, migration and invasion. Notch3 was found to be a downstream target of miR-34a with KCNQ1OT1 markedly inducing Notch3 expression in BC. Evidence for KCNQ1OT1/miR-34a/Notch3 axis was further established in clinical BC samples.We identified a KCNQ1OT1/miR-34a/Notch3 axis which promotes BC progression through effects on cell proliferation and metastasis that was further associated with poor patient prognosis. These results propose targeting this axis as novel treatment approach for BC.
- Published
- 2022
3. Increased risk of secondary bladder cancer after radiation therapy for endometrial cancer
- Author
-
Li Wen, Guansheng Zhong, and Min Ren
- Subjects
Gynaecological cancer ,Multidisciplinary ,Neoplasms, Radiation-Induced ,Radiotherapy ,Incidence ,Science ,Brachytherapy ,Neoplasms, Second Primary ,Urological cancer ,Survival Analysis ,Article ,Endometrial Neoplasms ,Cancer epidemiology ,Urinary Bladder Neoplasms ,Risk Factors ,Humans ,Medicine ,Female - Abstract
To investigate the effect of radiation therapy (RT) after endometrial cancer (EC) diagnosis on the risk of occurring secondary bladder cancer (SBC) as well as on the survival outcome of those patients who suffered with SBC. Data was extracted from the Surveillance, Epidemiology, and End Results database between 1973 and 2015. Chi-squared test was utilized to compare clinicopathological characteristics among different groups. The Fine and Gray’s competing risk model was utilized to assess cumulative incidence and risk of occurring SBC in EC survivors. The Kaplan–Meier method and the Cox regression model were used for survival analysis. As a result, a total of 108,060 EC patients were included, among which 37,118 (34.3%) patients received RT while others did not. The incidence of SBC was 1.31%, 1.76% and 0.96% among patients who received prior brachytherapy, external-beam radiotherapy (EBRT) and others, respectively. Both of the EBRT (standardized incidence ratio (SIR) = 2.24, 95% CI [1.94–2.58]) and brachytherapy (SIR = 1.76, 95% CI [1.44–2.13]) group had a higher incidence of SBC than the general population in USA. The competing risk analysis demonstrated that receiving EBRT (HR = 1.97, 95% CI [1.64–2.36]) or brachytherapy (HR = 1.46, 95% CI [1.14–1.87]) were all independent risk factors for developing SBC. A survival detriment was only observed in SBC patients who received prior EBRT after EC diagnosis, but not for brachytherapy, when compared with those who did not undergo RT. Additionally, there were no significant survival differences between primary bladder cancer and SBC with or without prior RT history. Patients who underwent RT after EC had an increased risk of developing bladder cancer as secondary primary cancer. The prognosis of these SBC patients varied depending on types of RT that received after EC diagnosis.
- Published
- 2022
4. Prognostic significance of serum immunoglobulin paraprotein in mucosa‐associated lymphoid tissue (MALT) lymphoma
- Author
-
Yi‐Min Ren, Chun‐Yu Shang, Jin‐Hua Liang, Hua Yin, Yi Xia, Jia‐Zhu Wu, Li Wang, Li Jian‐Yong, Yue Li, and Wei Xu
- Subjects
Mucous Membrane ,Immunoglobulin M ,Lymphoid Tissue ,Paraproteinemias ,Humans ,Lymphoma, B-Cell, Marginal Zone ,Hematology ,Prognosis ,Paraproteins ,Retrospective Studies - Abstract
To assess the prognostic significance of immunoglobulin (Ig) paraproteinaemia in mucosa-associated lymphoid tissue (MALT) lymphoma, 218 patients diagnosed with MALT lymphoma were enrolled in this study. Serum Ig paraprotein was detected in 42 of 218 patients (19.3%), mostly IgM-K (15, 35.7%), followed by IgM-L and IgG-L. Advanced age (p = 0.025), poor Eastern Cooperative Oncology Group performance status (p = 0.014), bone marrow involvement (p = 0.019), B symptoms (p = 0.039), advanced disease stage (III-IV) (p 0.0001), elevated serum β2-microglobulin level (p 0.0001), multiple extranodal sites of involvement (p 0.0001), nodal involvement (p 0.0001), systemic therapy (p 0.0001) and higher MALT-lymphoma International Prognostic Index (MALT-IPI) scores (p = 0.001) were significantly associated with the presence of serum Ig paraprotein. Multivariate Cox regression analysis showed that Ig paraproteinaemia was an independent prognostic predictor for inferior progression-free survival (PFS) and overall survival. A new prognostic index based on MALT-IPI and Ig paraproteinaemia, as assessed using receiver operating characteristic curves and the area under the curve statistics, showed better discriminative ability than MALT-IPI in predicting PFS. In conclusion, Ig paraproteinaemia was a promising prognostic predictor for MALT lymphoma. Ig paraproteinaemia together with MALT-IPI might contribute to optimising therapeutic management in clinical practice.
- Published
- 2021
5. Epidemiology of norovirus gastroenteritis in hospitalized children under five years old in western China, 2015–2019
- Author
-
Baoning Wang, Yu Kuang, Yuan Yang, Linlin Zhou, Hongren Wang, Xiaozhen Ma, Mingyuan Li, Wanyi Li, Jiangzhou You, Zhong-Yi Zhao, Ran-Ran Cao, and Min Ren
- Subjects
Male ,0301 basic medicine ,Genes, Viral ,Epidemiology ,viruses ,medicine.disease_cause ,Feces ,fluids and secretions ,0302 clinical medicine ,Risk Factors ,Rotavirus ,Genotype ,Immunology and Allergy ,030212 general & internal medicine ,Children ,Phylogeny ,Caliciviridae Infections ,biology ,Under-five ,Coinfection ,virus diseases ,General Medicine ,QR1-502 ,Gastroenteritis ,Hospitalization ,Infectious Diseases ,Child, Preschool ,Viruses ,Female ,Seasons ,Microbiology (medical) ,China ,medicine.medical_specialty ,Genotypes ,030106 microbiology ,West China ,Microbiology ,Virus ,Astrovirus ,03 medical and health sciences ,medicine ,Humans ,General Immunology and Microbiology ,business.industry ,Norovirus ,Infant, Newborn ,Infant ,Sapovirus ,biology.organism_classification ,Virology ,digestive system diseases ,business - Abstract
Objectives: Norovirus is associated with one-fifth of all gastroenteritis cases, but basic epidemiological data is lacking, especially in developing countries. As long-term surveillance on norovirus gastroenteritis is scarce in western China, this study aims to update the epidemiological knowledge of norovirus gastroenteritis and to characterize the genotypes of norovirus strains. Methods: Stool samples were collected from hospitalized children under 5 years old with gastroenteritis in Chengdu, China. All samples were tested for norovirus as well as rotavirus, sapovirus, enteric adenovirus, and astrovirus by real-time RT-PCR. RdRp and VP1 genes were sequenced in norovirus-positive samples to investigate viral phylogenies. Results: Of the 1181 samples collected from 2015 to 2019, 242 (20.5%) were positive for norovirus.Among norovirus-positive cases, 65 cases had co-infection with another virus; norovirus/enteric adenovirus was most frequently detected (50.8%, 33/65). The highest positive rate was observed in children aged 13–18 months (23.7%, 68/287). Norovirus infection peaked in autumn (36.6%, 91/249), followed by summer (20.3%, 70/345). Pearson correlation analysis showed significant correlation between the norovirus-positive rate and humidity (r = 0.773, P
- Published
- 2021
6. DJ-1 activates the AMPK/mTOR pathway by binding RACK1 to induce autophagy and protect the myocardium from ischemia/hypoxia injury
- Author
-
Xiao-Yan Zhao, Jian-Min Ren, Hui-Ru Liu, Ting-Ting Zhou, Xue-Ying Wang, Song Liu, and He-Ping Chen
- Subjects
Myocardium ,TOR Serine-Threonine Kinases ,Protein Deglycase DJ-1 ,Biophysics ,Cell Biology ,AMP-Activated Protein Kinases ,Receptors for Activated C Kinase ,Biochemistry ,Rats ,Neoplasm Proteins ,Rats, Sprague-Dawley ,Heart Injuries ,Ischemia ,Autophagy ,Animals ,Humans ,Hypoxia ,Molecular Biology - Abstract
Myocardial Ischemic Injury is a serious threat to human health, and DJ-1 is involved in cardioprotection. The research intended to explore the effects and mechanism of DJ-1 to protect myocardium against ischemia injury. DJ-1 overexpression lentivirus vectors were transduced into the myocardium of SD rats and H9c2 cells, and an AMI model in vivo and a hypoxia model in vitro were established, respectively. Results showed that DJ-1 overexpression alleviated myocardial ischemia injury, as demonstrated by reduced the extent of myocardial infarction, improved cell survival, decreased LDH activity and CK-MB release. Furthermore, DJ-1 interacted with RACK1, activated AMPK/mTOR pathway, induced adaptive autophagy and protected the myocardium. However, RACK1 siRNA or compound C (an AMPK inhibitor) could weaken the above effect of DJ-1 on myocardium. In conclusion, DJ-1 could activate adaptive autophagy by the RACK1/AMPK/mTOR pathway and protect the myocardium against ischemia injury.
- Published
- 2022
7. Bioactive AIEgens Tailored for Specific and Sensitive Theranostics of Gram-Positive Bacterial Infection
- Author
-
Yunxia Wang, Min Ren, Ying Li, Feng Liu, Yu Wang, Zhijun Wang, and Liheng Feng
- Subjects
Oxygen ,Photosensitizing Agents ,Bacteria ,Humans ,General Materials Science ,Precision Medicine ,Reactive Oxygen Species ,Gram-Positive Bacteria ,Gram-Positive Bacterial Infections ,Anti-Bacterial Agents - Abstract
Diseases caused by bacterial infections are increasingly threatening human health. As a major part of the microbial family, Gram-positive bacteria induce severe infections in hospitals and communities. Therefore, developing antibacterial materials that can recognize bacteria and specifically kill them is significant to cope with fatal bacterial infection. To this end, we designed and prepared a series of positively charged photosensitizers with an aggregation-induced emission feature and a type I reactive oxygen species (ROS) generation ability. Based on a molecular engineering strategy, the PS abbreviated to MTTTPy that owns a superior ROS generation ability and red emission in aggregation is obtained by adjusting bridging groups. Due to the unique molecular structure, MTTTPy can sensitively and specifically recognize and light up Gram-positive bacteria through electrostatic adsorption and void permeability. In addition, it can kill 95% of the recognized bacteria at a low concentration of 0.5 μM by generating oxygen-independent ROS under white light irradiation. Both in vitro and in vivo studies verify the sensitive and specific recognition and killing effect of MTTTPy toward Gram-positive bacteria. This work provides superior material-integrated diagnosis and treatment for Gram-positive bacteria-caused infectious diseases and shows potential for addressing bacterial resistance.
- Published
- 2022
8. Characterization and Management of Adverse Reactions in Patients with Advanced Endometrial Carcinoma Treated with Lenvatinib Plus Pembrolizumab
- Author
-
Lea Dutta, Vicky Makker, Melissa Zale, Matthew H. Taylor, Ana Oaknin, David M. O'Malley, Antonio Casado Herraez, Robert Orlowski, and Min Ren
- Subjects
Cancer Research ,medicine.medical_specialty ,Combination therapy ,Nausea ,Context (language use) ,Endometrial carcinoma ,Pembrolizumab ,Antibodies, Monoclonal, Humanized ,chemistry.chemical_compound ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,Humans ,Lenvatinib ,Medicine ,business.industry ,Phenylurea Compounds ,Endometrial cancer ,Gynecologic Oncology ,medicine.disease ,Endometrial Neoplasms ,Management ,Oncology ,chemistry ,Concomitant ,Quinolines ,Vomiting ,Female ,medicine.symptom ,business ,Adverse reactions - Abstract
Background The combination of lenvatinib plus pembrolizumab has shown efficacy in treatment of advanced endometrial carcinoma (that is not microsatellite instability–high or mismatch repair deficient) following prior systemic therapy in any setting in the open‐label, single‐arm, phase Ib/II Study 111/KEYNOTE‐146. With the exception of hypothyroidism, the safety profile of the combination was comparable to that of each monotherapy. Given the medical complexity and fragility of patients with endometrial carcinoma, further characterization of adverse reactions (ARs) associated with treatment will help health care professionals to optimize treatment with lenvatinib plus pembrolizumab combination therapy. Patients and Methods In Study 111/KEYNOTE‐146, patients received lenvatinib at a starting dose of 20 mg orally once daily and pembrolizumab 200 mg intravenously every 3 weeks. Selected ARs (hypertension, fatigue, nausea/vomiting, diarrhea, decreased appetite/weight loss, hypothyroidism, palmar‐plantar erythrodysesthesia syndrome, musculoskeletal pain, stomatitis, and proteinuria) were chosen for detailed post hoc analyses. Results Median times to first onset of the selected ARs in this analysis all occurred within the first 10 weeks of treatment. Of the selected ARs, grade ≥3 severity of fatigue, hypertension, and nausea occurred in ≥5% of patients. Overall incidence of hypothyroidism was 51%, primarily of grade 2 severity (46%). Most of the ARs assessed were managed with a combination of study drug dose modifications and concomitant medications. Conclusion No new safety signals were identified and the toxicity profile in this study was manageable with supportive medications, dose interruptions, and/or lenvatinib dose reductions. This analysis provides AR management guidance for patients with endometrial cancer receiving lenvatinib plus pembrolizumab combination therapy. Implications for Practice Lenvatinib plus pembrolizumab has shown efficacy in the treatment of patients with advanced endometrial carcinoma (that is, not microsatellite instability–high or mismatch repair deficient) following at least one prior systemic therapy in any setting. Patients may experience toxicity associated with this combination, including adverse reactions of hypertension, fatigue, nausea/vomiting, diarrhea, decreased appetite/weight loss, hypothyroidism, palmar‐plantar erythrodysesthesia syndrome, musculoskeletal pain, stomatitis, and proteinuria. These adverse reactions may be managed with a combination of concomitant supportive care medications and judicious lenvatinib dose modifications. This article provides context and guidance for the recognition and management of adverse reactions in patients receiving lenvatinib plus pembrolizumab., This article provides context and guidance for the recognition and management of adverse reactions in patients receiving lenvatinib plus pembrolizumab for the treatment of endometrial carcinoma.
- Published
- 2021
9. Deep Sequencing of HPV16 E6 Region Reveals Unique Mutation Pattern of HPV16 and Predicts Cervical Cancer
- Author
-
Wenchao Ai, Chuanyong Wu, Liqing Jia, Xiao Xiao, Xuewen Xu, Min Ren, Tian Xue, Xiaoyan Zhou, Ying Wang, and Chunfang Gao
- Subjects
Microbiology (medical) ,Human papillomavirus 16 ,General Immunology and Microbiology ,Ecology ,Physiology ,Squamous Intraepithelial Lesions ,Papillomavirus Infections ,High-Throughput Nucleotide Sequencing ,Uterine Cervical Neoplasms ,Cell Biology ,Infectious Diseases ,Mutation ,Genetics ,Humans ,Female ,Tumor Suppressor Protein p53 - Abstract
The genetic diversity of human papillomavirus (HPV) 16 within cervical cells and tissue is usually associated with persistent virus infection and precancerous lesions. To explore the HPV16 mutation patterns contributing to the cervical cancer (CC) progression, a total of 199 DNA samples from HPV16-positive cervical specimens were collected and divided into high-grade squamous intraepithelial lesion (HSIL) and the non-HSIL(NHSIL) groups. The HPV16 E6 region (nt 7125-7566) was sequenced using next-generation sequencing. Based on HPV16 E6 amino acid mutation features selected by Lasso algorithm, four machine learning approaches were used to establish HSIL prediction models. The receiver operating characteristic was used to evaluate the model performance in both training and validation cohorts. Western blot was used to detect the degradation of p53 by the E6 variants. Based on the 13 significant mutation features, the logistic regression (LR) model demonstrated the best predictive performance in the training cohort (AUC = 0.944, 95% CI: 0.913-0.976), and also achieved a high discriminative ability in the independent validation cohort (AUC = 0.802, 95% CI: 0.601-1.000). Among these features, the E6 D32E and H85Y variants have higher ability to degrade p53 compared to the E6 wildtype (
- Published
- 2022
10. Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study
- Author
-
Bei, Qian, Jing, Yang, Jun, Zhou, Longqing, Hu, Shoupeng, Zhang, Min, Ren, and Xincai, Qu
- Subjects
Nomograms ,Ki-67 Antigen ,Endocrinology, Diabetes and Metabolism ,Humans ,Breast Neoplasms ,Female ,Neoadjuvant Therapy ,Retrospective Studies - Abstract
BackgroundPathological complete response (pCR) is considered a surrogate for favorable survival in breast cancer (BC) patients treated with neoadjuvant chemotherapy (NACT), which is the goal of NACT. This study aimed to develop and validate a nomogram for predicting the pCR probability of BC patients after NACT based on the clinicopathological features.MethodsA retrospective analysis of 527 BC patients treated with NACT between January 2018 and December 2021 from two institutions was conducted. Univariate and multivariate logistic regression analyses were performed to select the most useful predictors from the training cohort (n = 225), and then a nomogram model was developed. The performance of the nomogram was evaluated with respect to its discrimination, calibration, and clinical usefulness. Internal validation and external validation were performed in an independent validation cohort of 96 and 205 consecutive BC patients, respectively.ResultsAmong the 18 clinicopathological features, five variables were selected to develop the prediction model, including age, American Joint Committee on Cancer (AJCC) T stage, Ki67 index before NACT, human epidermal growth factor receptor 2 (HER2), and hormone receptor (HR) status. The model showed good discrimination with an area under the receiver operating characteristic curve (AUC) of 0.825 (95% CI, 0.772 to 0.878) in the training cohort, and 0.755 (95% CI, 0.658 to 0.851) and 0.79 (95% CI, 0.724 to 0.856) in the internal and external validation cohorts, respectively. The calibration curve presented good agreement between prediction by nomogram and actual observation, and decision curve analysis (DCA) indicated that the nomogram had good net benefits in clinical scenarios.ConclusionThis study constructed a validated nomogram based on age, AJCC T stage, Ki67 index before NACT, HER2, and HR status, which could be non-invasively applied to personalize the prediction of pCR in BC patients treated with NACT.
- Published
- 2022
11. The association of triglyceride and glucose index, and triglyceride to high‐density lipoprotein cholesterol ratio with prehypertension and hypertension in normoglycemic subjects: A large cross‐sectional population study
- Author
-
Xiaomeng Xing, Zhigang Guo, Fomin Zhang, Yingyi Zhang, Hongliang Cong, Hua Yang, and Min Ren
- Subjects
Adult ,Blood Glucose ,medicine.medical_specialty ,hypertension ,triglyceride and glucose index ,Endocrinology, Diabetes and Metabolism ,030204 cardiovascular system & hematology ,Prehypertension ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,High-density lipoprotein ,Insulin resistance ,Internal medicine ,insulin resistance ,triglyceride to high‐density lipoprotein cholesterol ratio ,Internal Medicine ,medicine ,Humans ,030212 general & internal medicine ,Triglycerides ,Triglyceride ,Cholesterol ,business.industry ,Cholesterol, HDL ,medicine.disease ,Blood pressure ,Endocrinology ,Cross-Sectional Studies ,Glucose ,chemistry ,Quartile ,Dyslipidemia ,Population study ,Original Article ,Cardiology and Cardiovascular Medicine ,business ,Biomarkers - Abstract
Insulin resistance (IR) plays an important role in the development of hypertension. Triglyceride and glucose index (TyG index), and triglyceride to high‐density lipoprotein cholesterol ratio (TG/HDL‐c) as effective IR surrogate indexes have been verified in numerous studies. Therefore, the authors conducted a large cross‐sectional study to explore the association of TyG index and TG/HDL‐c with prehypertension and hypertension in the same normoglycemic subjects from Tianjin, China. A total of 32 124 adults were eligible for this study. According to the level of blood pressure, the enrolled individuals were divided into three groups, which were normotension, prehypertension, and hypertension. In multiple logistic regression analysis, there was associated with prehypertension and hypertension when comparing the highest TyG index to the lowest TyG index and corresponding ORs were 1.795 (1.638, 1.968) and 2.439 (2.205, 2.698), respectively. For TG/HDL‐c, the corresponding ORs were 1.514 (1.382, 1.658) and 1.934 (1.751, 2.137), respectively. Furthermore, when comparing the fourth quartile to the first quartile of TyG index and TG/HDL‐c, respectively, both corresponding ORs of hypertension were higher than prehypertension. Elevated TyG index and TG/HDL‐c levels were associated with prehypertension and hypertension in normoglycemic individuals. Moreover, the TyG index was more significant than TG/HDL‐c in distinguishing hypertension. They have the potential to become cost‐effective monitors in the hierarchical management of prehypertension and hypertension.
- Published
- 2021
12. Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT
- Author
-
Richard S. Finn, Zhenggang Ren, Corina E. Dutcus, Masahiro Kobayashi, Ann-Lii Cheng, Masatoshi Kudo, Jung Hwan Yoon, Minshan Chen, Fabio Piscaglia, Kalgi Mody, Kenji Ikeda, Min Ren, Max W. Sung, Shukui Qin, Toshiyuki Tamai, Hiromitsu Kumada, Lucjan Wyrwicz, Kwang Hyub Han, Seiichi Hayato, Takuji Okusaka, Okusaka T., Ikeda K., Kudo M., Finn R., Qin S., Han K.-H., Cheng A.-L., Piscaglia F., Kobayashi M., Sung M., Chen M., Wyrwicz L., Yoon J.-H., Ren Z., Mody K., Dutcus C., Tamai T., Ren M., Hayato S., and Kumada H.
- Subjects
Adult ,Male ,Sorafenib ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Hepatocellular carcinoma ,Phases of clinical research ,Antineoplastic Agents ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,Post-hoc analysis ,medicine ,Humans ,Lenvatinib ,Dosing ,Adverse effect ,Aged ,Aged, 80 and over ,Original Article—Liver, Pancreas, and Biliary Tract ,Dose-Response Relationship, Drug ,business.industry ,Phenylurea Compounds ,Liver Neoplasms ,Gastroenterology ,Middle Aged ,Body weight ,medicine.disease ,Confidence interval ,Treatment Outcome ,chemistry ,030220 oncology & carcinogenesis ,Quinolines ,Female ,REFLECT ,030211 gastroenterology & hepatology ,business ,medicine.drug - Abstract
Background REFLECT was an open-label, phase 3 study comparing the efficacy and safety of lenvatinib versus sorafenib in patients with unresectable hepatocellular carcinoma (uHCC). Based on phase 2 study (Study 202) results, body weight-based dosing for lenvatinib was used in REFLECT to minimize dose disruptions and modifications needed to address dose-related adverse events. This post hoc analysis of REFLECT data assessed lenvatinib efficacy and safety by body weight group. Methods The study randomly administered lenvatinib (n = 476) or sorafenib (n = 475) to patients with untreated (no prior systemic therapy) uHCC. Lenvatinib starting-dose data were stratified by body weight: patients weighing Results Survival outcomes and safety profiles appeared similar between the two body-weight-based lenvatinib starting-dose groups. Median OS for patients in the n = 153) was 13.4 months [95% confidence interval (CI) 10.5–15.7] compared to 13.7 months (95% CI 12.0–15.6) in the ≥ 60 kg body weight group (n = 325). In both lenvatinib groups, PFS was 7.4 months ( Conclusions This exploratory analysis of data from REFLECT indicated that body weight-based lenvatinib dosing in patients with uHCC was successful in maintaining efficacy, with comparable rates of TEAEs and dose modifications in the two body weight groups. Clinincal trial Trial registration ID: ClinicalTrials.gov # NCT01761266
- Published
- 2021
13. Impact of lung metastases on overall survival in the phase 3 SELECT study of lenvatinib in patients with radioiodine-refractory differentiated thyroid cancer
- Author
-
Corin Badiu, Min Ren, Takuya Suzuki, Corina E. Dutcus, Ana O. Hoff, Makoto Tahara, Lori J. Wirth, Taofeek K. Owonikoko, and Naomi Kiyota
- Subjects
Male ,0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,Lung Neoplasms ,Time Factors ,Phases of clinical research ,Antineoplastic Agents ,Placebo ,Radiation Tolerance ,Iodine Radioisotopes ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Double-Blind Method ,Refractory ,Internal medicine ,medicine ,Overall survival ,Humans ,In patient ,Thyroid Neoplasms ,Protein Kinase Inhibitors ,Thyroid cancer ,Aged ,Lung ,business.industry ,Phenylurea Compounds ,Cell Differentiation ,Middle Aged ,medicine.disease ,Progression-Free Survival ,Tumor Burden ,030104 developmental biology ,medicine.anatomical_structure ,chemistry ,030220 oncology & carcinogenesis ,Quinolines ,Female ,Radiopharmaceuticals ,Lenvatinib ,business - Abstract
Lung metastases may worsen overall survival (OS) in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC). We investigated (post hoc) the impact of lung metastases on survival in SELECT (a phase 3 study).392 patients with RR-DTC were randomised 2:1 to lenvatinib 24 mg daily (n = 261) or placebo (n = 131). Placebo-treated patients could crossover to open-label lenvatinib following progression. Patients were grouped by size of baseline lung metastases. Safety/efficacy outcomes, collated by these lung-metastases subgroups, were generated.Lenvatinib-treated population distributions per baseline lung metastases subgroup were any lung metastases (target/nontarget lesions; n = 226), and by maximum size of target lung lesions ≥1.0 cm (n = 199), ≥1.5 cm (n = 150), ≥2.0 cm (n = 94) and2.0 cm (n = 105). In patients with any lung metastases, no statistically significant difference in OS was observed between treatment arms (HR: 0.76; 95% CI: 0.57-1.01; P = 0.0549). Median OS for lung metastases of ≥1.0 cm was 44.7 months (lenvatinib) versus 33.1 months (placebo) (HR: 0.63; 95% CI: 0.47-0.85; P = 0.0025). OS was significantly prolonged with lenvatinib versus placebo among patients with lung metastases of ≥1.0 cm, ≥1.5 cm, ≥2.0 cm and2.0 cm; median OS was shorter in the ≥2.0 cm subgroup (lenvatinib: 34.7 months) versus other subgroups (lenvatinib: 44.1-49.2 months). Multivariate analysis demonstrated lenvatinib significantly prolonged OS in patients with lung metastases of ≥1.0 cm after adjustment for baseline characteristics.Lenvatinib treatment resulted in longer OS in patients with lung metastases of ≥1.0 cm versus placebo (even with the 89% crossover rate). Early initiation of lenvatinib may improve outcomes in patients with RR-DTC and lung metastases of ≥1.0 cm.ClinicalTrials.Gov Identifier: NCT01321554.
- Published
- 2021
14. Human infection of avian influenza A H3N8 virus and the viral origins: a descriptive study
- Author
-
Rengui Yang, Honglei Sun, Feng Gao, Kaiwei Luo, Zheng Huang, Qi Tong, Hao Song, Qiqi Han, Jiyu Liu, Yu Lan, Jianxun Qi, Han Li, Shuilian Chen, Mingzhong Xu, Jinsong Qiu, Ge Zeng, Xixing Zhang, Chaoyang Huang, Ruiqing Pei, Zhifei Zhan, Beiwei Ye, Yaxin Guo, Yinzhu Zhou, Wen Ye, Dong Yao, Min Ren, Bo Li, Jizhe Yang, Yanan Wang, Juan Pu, Yipeng Sun, Yi Shi, William J Liu, Xinhua Ou, George F Gao, Lidong Gao, and Jinhua Liu
- Subjects
Microbiology (medical) ,Mammals ,COVID-19 ,Microbiology ,Poultry ,Influenza A Virus, H3N8 Subtype ,Infectious Diseases ,Ducks ,Virology ,Child, Preschool ,Influenza in Birds ,Influenza, Human ,Influenza A Virus, H9N2 Subtype ,Humans ,Animals ,Chickens ,Phylogeny ,Retrospective Studies - Abstract
The H3N8 avian influenza virus (AIV) has been circulating in wild birds, with occasional interspecies transmission to mammals. The first human infection of H3N8 subtype occurred in Henan Province, China, in April, 2022. We aimed to investigate clinical, epidemiological, and virological data related to a second case identified soon afterwards in Hunan Province, China.We analysed clinical, epidemiological, and virological data for a 5-year-old boy diagnosed with H3N8 AIV infection in May, 2022, during influenza-like illness surveillance in Changsha City, Hunan Province, China. H3N8 virus strains from chicken flocks from January, 2021, to April, 2022, were retrospectively investigated in China. The genomes of the viruses were sequenced for phylogenetic analysis of all the eight gene segments. We evaluated the receptor-binding properties of the H3N8 viruses by using a solid-phase binding assay. We used sequence alignment and homology-modelling methods to study the effect of specific mutations on the human receptor-binding properties. We also conducted serological surveillance to detect the H3N8 infections among poultry workers in the two provinces with H3N8 cases.The clinical symptoms of the patient were mild, including fever, sore throat, chills, and a runny nose. The patient's fever subsided on the same day of hospitalisation, and these symptoms disappeared 7 days later, presenting mild influenza symptoms, with no pneumonia. An H3N8 virus was isolated from the patient's throat swab specimen. The novel H3N8 virus causing human infection was first detected in a chicken farm in Guangdong Province in December, 2021, and subsequently emerged in several provinces. Sequence analyses revealed the novel H3N8 AIVs originated from multiple reassortment events. The haemagglutinin gene could have originated from H3Ny AIVs of duck origin. The neuraminidase gene belongs to North American lineage, and might have originated in Alaska (USA) and been transferred by migratory birds along the east Asian flyway. The six internal genes had originated from G57 genotype H9N2 AIVs that were endemic in chicken flocks. Reassortment events might have occurred in domestic ducks or chickens in the Pearl River Delta area in southern China. The novel H3N8 viruses possess the ability to bind to both avian-type and human-type sialic acid receptors, which pose a threat to human health. No poultry worker in our study was positive for antibodies against the H3N8 virus.The novel H3N8 virus that caused human infection had originated from chickens, a typical spillover. The virus is a triple reassortment strain with the Eurasian avian H3 gene, North American avian N8 gene, and dynamic internal genes of the H9N2 viruses. The virus already possesses binding ability to human-type receptors, though the risk of the H3N8 virus infection in humans was low, and the cases are rare and sporadic at present. Considering the pandemic potential, comprehensive surveillance of the H3N8 virus in poultry flocks and the environment is imperative, and poultry-to-human transmission should be closely monitored.National Natural Science Foundation of China, National Key Research and Development Program of China, Strategic Priority Research Program of the Chinese Academy of Sciences, Hunan Provincial Innovative Construction Special Fund: Emergency response to COVID-19 outbreak, Scientific Research Fund of Hunan Provincial Health Department, and the Hunan Provincial Health Commission Foundation.
- Published
- 2022
15. [Research on the Construction of Hospital Equipment Management Information Platform]
- Author
-
Xiao-Min, Ren, Hao-Yang, Zhou, Rong-Gao, Tang, and Jie, Yang
- Subjects
China ,Information Dissemination ,Information Management ,Humans ,Equipment and Supplies, Hospital ,Hospitals - Abstract
With the deepening of China's medical reform, the scale of hospital equipment assets at all levels is also expanding. In the face of large-scale and various equipment assets, the traditional single machine statistical management method not only has a single interface, poor data accuracy and is not compatible with other systems, but also is difficult to achieve "full life cycle" management. In order to solve above problems, the Ninth People's Hospital Affiliated to Shanghai Jiao Tong University of Medicine aims to use the Internet of Things to build a medical equipment management information platform, realize the whole hospital area, whole subject and whole process management of medical materials, and achieve the objectives of business linkage, information connectivity and data sharing between management departments and clinical departments.
- Published
- 2022
16. Distribution of risk factors of hypertension patients in different age groups in Tianjin
- Author
-
Ying Zhang, Fumei Zhao, Ting Liu, Zhigang Guo, Hua Yang, Hongliang Cong, Yingyi Zhang, Ruiying Wang, and Min Ren
- Subjects
Adult ,Male ,medicine.medical_specialty ,Waist ,Adolescent ,030204 cardiovascular system & hematology ,Waist-to-height ratio ,Body Mass Index ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Diabetes mellitus ,Epidemiology ,Prevalence ,medicine ,Humans ,030212 general & internal medicine ,Risk factor ,Family history ,Aged ,Awareness rate ,Waist-Height Ratio ,Different age groups ,Waist-Hip Ratio ,business.industry ,lcsh:Public aspects of medicine ,Hypertriglyceridemia ,Public Health, Environmental and Occupational Health ,lcsh:RA1-1270 ,Middle Aged ,medicine.disease ,Obesity ,Cross-Sectional Studies ,Risk factors ,Hypertension ,Waist Circumference ,business ,Research Article - Abstract
Background To analyze the risk factors for hypertension in different age groups of urban and rural residents in Tianjin. Methods A total of 33,997 people (35–75 years old) from 13 community health service centers and primary hospitals in Tianjin participated in this study. They were divided into the youth group (≤ 40 years old), middle-aged group (41–65 years old), and elderly group (> 65 years old). Then, a questionnaire survey was administered, followed by physical and blood biochemical examinations. The demographic characteristics and prevalence were recorded and counted. Subsequently, risk factors were analyzed using univariate and stepwise multivariate logistic regression analysis. Results In the youth, middle-aged, and elderly groups, the prevalence rate of hypertension was 18.65, 51.80, and 76.61%, respectively. Logistic regression analysis showed that obesity(OR: 3.263, 95% CI: 1.039–1.656), men (OR: 2.117, 95% CI: 1.691–2.651), diabetes (OR: 1.978, 95% CI: 1.398–2.799), high triglycerides(OR 1.968 95% CI: 1.590–2.434) and family history of stroke (OR: 1.936, 95% CI: 1.287–2.911) are the five factors in youth. In middle-aged group, the significantly associating factors were obesity (OR: 2.478, 95% CI: 2.330–2.636), diabetes (OR: 2.173, 95% CI: 1.398–2.799), family history of stroke (OR: 1.808, 95% CI: 1.619–2.020), maleness (OR: 1.507, 95% CI: 1.412–1.609),Hypertriglyceridemia (OR 1.490 95% CI: 1.409–1.577),family history of cardiovascular disease (OR: 1.484, 95% CI: 1.307–1.684),Hypercholesterolemia (OR 1.228 95% CI: 1.160–1.299). In the elderly group, obesity (OR: 2.104, 95% CI: 1.830–2.418), family history of strokes (OR: 1.688, 95% CI: 1.243–2.292), diabetes mellitus (OR: 1.544, 95% CI: 1.345–1.773), family history of cardiovascular disease (OR: 1.470, 95% CI: 1.061–2.036), hypertriglyceridemia (OR: 1.348, 95% CI: 1.192–1.524) increased the risk for hypertension. Waist circumference (WC) and waist-to-height ratio (WHtR) increased with age, and the value of these two measures for predicting hypertension was better than BMI in middle-aged group. Conclusion Obesity is the most important risk factor for hypertension in all age groups. Diabetes, family history of strokes and high triglyceride were also significant risk factors for all age groups. There was a gender difference between the young and middle-aged groups, with men more likely to hypertension. Waist circumference (WC) and waist-to-height ratio (WHtR) were better predictors of hypertension than BMI in middle-aged group.
- Published
- 2021
17. Clinicopathological, immunohistochemical and fluorescence in‐situ hybridisation features of early subungual melanoma: an analysis of 65 cases
- Author
-
Min Ren, Xu Cai, Bo Dai, Jin-Cheng Kong, Xuxia Shen, Jing Ren, and Yun-Yi Kong
- Subjects
Adult ,Male ,0301 basic medicine ,Pathology ,medicine.medical_specialty ,Skin Neoplasms ,Histology ,Melanocyte ,Pathology and Forensic Medicine ,Cohort Studies ,Breslow Thickness ,Nail Diseases ,03 medical and health sciences ,MART-1 Antigen ,0302 clinical medicine ,Biomarkers, Tumor ,medicine ,Humans ,Nuclear atypia ,Melanoma ,In Situ Hybridization, Fluorescence ,Retrospective Studies ,Skin ,medicine.diagnostic_test ,SOXE Transcription Factors ,business.industry ,S100 Proteins ,General Medicine ,Middle Aged ,medicine.disease ,Immunohistochemistry ,Staining ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Monoclonal ,Melanocytes ,Female ,business ,Fluorescence in situ hybridization - Abstract
Aims Very limited data are available concerning the clinicopathological and molecular features of early subungual melanoma (SM), especially with regard to the Asian population. The aim of this study was to investigate the clinical, histological, immunohistochemical and chromosomal features of early SM. Methods and results Fifty-two in-situ and 13 thin (Breslow thickness ≤1.0 mm) SM cases were retrospectively reviewed. All patients presented with longitudinal melanonychia involving a single digit, and the thumb was the most affected digit (35 of 65, 53.8%). Microscopically, most cases showed small to medium nuclear enlargement (58 of 65) and mild to moderate nuclear atypia (57 of 65). Hyperchromatism and irregular contours of nuclei were persistent features in all cases. The variation of melanocyte count (the number of melanocytes per mm dermal-epithelial junction) ranged from 31 to 255. Intra-epithelial mitoses were identified in 34 cases (52.3%). Statistically, features of in-situ lesions including higher melanocyte count (>70), presence of multinucleated melanocytes, inflammatory infiltrate and cutaneous adnexal extension, were associated with early invasion. Melan-A, human melanoma B (HMB)45, mouse monoclonal melanoma antibody (PNL2) and SOX10 antibodies (>95.0%) showed superior diagnostic sensitivity to S-100 protein (83.1%). Fluorescence in-situ hybridisation (FISH) results were positive in 15 of 23 successfully analysed cases. Conclusions To the best of our knowledge, this is the largest single-institution study of early SM in an Asian population, and the largest cohort tested by FISH. Early SM mainly showed small to medium nuclear enlargement and mild to moderate nuclear atypia. High melanocyte count, hyperchromatism and irregular contours of nuclei and intra-epithelial mitoses are crucial diagnostic parameters. Immunohistochemistry, especially SOX10 staining, and FISH analysis are valuable in the diagnosis of SM.
- Published
- 2020
18. A population-based predictive model to identify patients with signet ring cell carcinoma of the stomach who are most suitable for primary tumor resection
- Author
-
Biao Hu, Run-Pu Zou, Yin-Wen Gan, Yi-Hao Zhu, Si-Min Ren, Wei-Zhong Hou, Zhi-Xin Xie, Ru Wang, Wen-Ting Yang, Peng-Ji Lin, Jun-Tao Feng, Zi-Min Gao, and Xu-Guang Guo
- Subjects
Nomograms ,Oncology ,Stomach ,Humans ,Surgery ,Propensity Score ,Carcinoma, Signet Ring Cell - Abstract
Background Though the survival benefit of primary tumor operation for patients with signet ring cell carcinoma of the stomach is known, the specific characteristics of those patients who would profit from the operation are yet to be determined. To this end, a predictive model was developed to identify the conjecture that the survival profit from primary tumor operation would only be obtained by patients. Method The clinical data of the patients with signet ring cell carcinoma of the stomach were obtained from the Surveillance, Epidemiology, and End Results database, and then divided into operation and no-operation groups based on whether the patients underwent the primary tumor operation. To remove the confounding factors, propensity score matching was employed, and it was hypothesized that the patients who had been operated on and lived a longer life than the median cancer-specific survival time of those who hadn’t must have profited from the surgery. To discuss the independent factors of cancer-specific survival time in the beneficial group and the non-beneficial group, the Cox model was used, and based on the various vital predictive factors, a nomogram was drawn using logistic regression. Result The number of eligible patients was 12,484, with 43.9% (5483) of them having received surgery. After employing propensity score matching, the cancer-specific survival time of the operation group was found to be apparently longer (median: 21 vs. 5 months; p < 0.001) than the no-operation group. In the operation group, 4757 (86.7%) of the patients lived longer than five months (beneficial group). The six indexes (beneficial and non-beneficial group) included gender, age, Tumor Node Metastasis stage, histologic type, differentiation grade, and tumor position, and were used as predictors to draw the nomogram. The nomogram was used to divide the patients who had taken operations into two groups: the beneficial operation group and the non-beneficial operation group. The beneficial operation group, it was found, survived longer than the non-beneficial operation group (median cancer-specific survival time: 28 vs. 3 months, p < 0.001). Moreover, there was we could tell little difference in survival between the two groups (median cancer-specific survival time: 3 vs. 5 months). Conclusions The predictive model created to select suitable candidates for surgical treatment from patients with signet ring carcinoma of the stomach could be adopted to identify certain patients benefiting from the primary tumor operation.
- Published
- 2022
19. Circ_0001174 facilitates osteosarcoma cell proliferation, migration, and invasion by targeting the miR-186-5p/MACC1 axis
- Author
-
Qingyu Wang, Feifei Lin, Xiaonan Wang, Xin Zhao, Min Ren, and Jincheng Wang
- Subjects
Gene Expression Regulation, Neoplastic ,MicroRNAs ,Osteosarcoma ,Cell Line, Tumor ,Trans-Activators ,Humans ,Bone Neoplasms ,Orthopedics and Sports Medicine ,Surgery ,RNA, Circular ,Real-Time Polymerase Chain Reaction ,Cell Proliferation - Abstract
Background Studies of aberrantly expressed circular RNAs (circRNAs) can provide insights into the molecular mechanisms of osteosarcoma (OS). However, the role of circ_0001174 in OS progression remains unknown. This study is aimed to identify differentially expressed circRNAs and messenger RNAs (mRNAs) in patients with OS and to investigate potential regulatory ways of circ_0001174. Methods High-throughput sequencing was performed to screen aberrantly expressed circRNAs and mRNAs between tumor and paracancerous tissues from patients with OS. Several bioinformatics tools were used to analyze the functions and pathways of the differentially expressed genes between the tissues. Cell counting kit-8, cell migration and invasion assays were performed to evaluate the functions of the critical circRNAs. RNA interference experiments, quantitative real-time polymerase chain reaction (RT-qPCR) and western blotting were used to explore the relationship between miR-186-5p and circ_0001174 or metastasis-associated in colon cancer 1 (MACC1). Results Compared with the paracancerous tissues, 109 circRNAs and 1264 mRNAs were differentially expressed in the OS tissues, including 88 circRNAs and 707 mRNAs that were upregulated and 21 circRNAs and 557 mRNAs that were downregulated. The expression of four upregulated and four downregulated circRNAs was validated using RT-qPCR; the results were consistent with the sequencing data, and circ_0001174 was found to be significantly upregulated in 16 pairs of OS tissues and OS cell lines (fold change > 2.0, P value Conclusions Abnormally high expression of circ_0001174 may promote the proliferation, migration, and invasion of OS cells through up-regulating MACC1 by sponging miR-186-5p. These results provide insight into therapeutic targets for preventing and treating OS.
- Published
- 2022
20. The lncRNA HOXA11‐AS acts as a tumor promoter in breast cancer through regulation of the miR‐125a‐5p/TMPRSS4 axis
- Author
-
Yunfeng, Xu, Zhiyao, Ren, Xin, Wang, and Min, Ren
- Subjects
Homeodomain Proteins ,Carcinogenesis ,Serine Endopeptidases ,Membrane Proteins ,Breast Neoplasms ,Gene Expression Regulation, Neoplastic ,Mice ,MicroRNAs ,Cell Line, Tumor ,Drug Discovery ,Carcinogens ,Genetics ,Animals ,Humans ,Molecular Medicine ,Female ,RNA, Long Noncoding ,Molecular Biology ,Genetics (clinical) ,Cell Proliferation - Abstract
Long non-coding RNAs (lncRNAs) play vital roles in tumorigenesis. Here, we explored how lncRNA HOXA11-AS functions in the progression of breast cancer (BC).HOXA11-AS and miR-125a-5p levels were measured by a quantitative real-time polymerase chain reaction, whereas western blotting determined TMPRSS4 levels in BC tumor tissues, adjacent normal tissues and BC cell lines. The roles of HOXA11-AS, miR-125a-5p and TMPRSS4 in BC proliferation were investigated using cell counting kit-8, colony formation and flow cytometry assays, whereas scratch and transwell assays were used to measure metastasis. RNA pull-down assays and dual-luciferase assays assessed direct interactions between HOXA11-AS and miR-125a-5p. The effects of HOXA11-AS in vivo were investigated in a BC xenograft model.HOXA11-AS was upregulated in tumor tissues of 56 BC patients compared to adjacent non-tumor tissues, with high levels being associated with worse overall survival. Silencing of HOXA11-AS inhibited the proliferation and metastasis of BC cells, leading to cell cycle arrest in G0/G1 and induction of apoptosis. We identified miR-125a-5p as a target of HOXA11-AS, with miR-125a-5p inhibitors partially restoring the reduction of cell proliferation and metastasis induced by HOXA11-AS silencing. We also determined that miR-125a-5p targeted TMPRSS4 mRNA, with HOXA11-AS knockdown and miR-125a-5p mimics suppressing TMPRSS4. Overexpression of TMPRSS4 partially compensated for the reduction of cell proliferation and metastasis induced by HOXA11-AS silencing. Finally, we confirmed the mechanism of HOXA11-AS in the regulation of tumorigenesis in the mouse model.HOXA11-AS regulates the tumorigenic ability of BC via the miR-125a-5p/TMPRSS4 axis. This provides insights for regulatory mechanisms involved in BC progression, and may enable new treatment strategies in the clinical setting.
- Published
- 2022
21. Benzotriazole Ultraviolet Stabilizers Promote Breast Cancer Cell Proliferation via Activating Estrogen-Related Receptors α and γ at Human-Relevant Levels
- Author
-
Sen He, Han Xiao, Shuang Luo, Xin Li, Jia-Da Zhang, Xiao-Min Ren, Yuan Yang, Xian-De Xie, Yao-Yu Zhou, Yu-Long Yin, Lin Luo, and Lin-Ying Cao
- Subjects
Receptors, Estrogen ,Environmental Chemistry ,Humans ,Breast Neoplasms ,Estrogens ,Female ,General Chemistry ,Triazoles ,Cell Proliferation - Abstract
Benzotriazole ultraviolet stabilizers (BUVSs) are ubiquitous emerging pollutants that have been reported to show estrogenic disruption effects through interaction with the classic estrogen receptors (ERs) in the fashion of low activity. The present study aims at revealing the potential disruption mechanism via estrogen-related receptors α and γ (ERRα and ERRγ) pathways. By the competitive binding assay, we first found that BUVSs bond to ERRγ ligand binding domain (ERRγ-LBD) with
- Published
- 2022
22. Detection of Klebsiella pneumoniae cfDNA in pleural fluid and its clinical value
- Author
-
Mingliang Chu, Min Ren, Lin Liu, and Li Li
- Subjects
medicine.medical_specialty ,Microbiological culture ,Pleural effusion ,Gastroenterology ,Sputum culture ,Internal medicine ,Humans ,Medicine ,Malignant pleural effusion ,Advanced and Specialized Nursing ,medicine.diagnostic_test ,business.industry ,Reproducibility of Results ,DNA ,Gold standard (test) ,respiratory system ,medicine.disease ,respiratory tract diseases ,Pleural Effusion ,Klebsiella pneumoniae ,Pneumonia ,Anesthesiology and Pain Medicine ,Hydrothorax ,Sputum ,medicine.symptom ,business ,Cell-Free Nucleic Acids - Abstract
Background Klebsiella pneumoniae (KP) is an important opportunistic pathogen that can easily cause pneumonia and pleural effusion when body resistance is reduced. However, the positive rate of KP detected from clinical pleural effusion by traditional methods, including bacterial culture, is meager. Therefore, new detection methods are urgently needed to improve the positive detection rate of KP and other bacteria in pleural effusion. Methods Simulated pleural fluid of KP infection was first set up. Then circulating cell-free DNA (cfDNA) was extracted from cultured hydrothorax and detected by fluorescence polymerase chain reaction (PCR) to verify KP cfDNA in the pleural fluid. The specificity, sensitivity, and repeatability of this method are verified by detecting the cfDNAs in pleural effusion, samples of malignant pleural effusion, tuberculous pleural effusion, and other common microbial infections. Finally, this method was compared with three traditional methods, pleural effusion, precipitation DNA, sputum culture, and pleural effusion culture to explore the clinical diagnostic value of this method. Results KP cfDNA was positive by fluorescence PCR from the simulated KP infected pleural effusion, which confirmed KP cfDNA in pleural effusion. KP cfDNA was positive by fluorescence PCR from the pleural effusion of KP infected patients, while with the same detection method, KP cfDNA in clinical carcinomatous hydrothorax, tuberculosis hydrothorax, and other standard microbial infection samples was negative, which confirmed the method had high specificity, high sensitivity, and reproducibility. Compared with the three traditional methods, this method has a higher positive rate. Compared with the gold standard, sputum bacterial culture, the sensitivity, specificity, positive predictive value, and negative predictive value of this method were 91.67%, 95.45%, 91.7%, and 95.5%, respectively. Conclusions The detection of cfDNA by fluorescence PCR is possible. Moreover, the positive rate of this method in clinical pleural effusions is high.
- Published
- 2020
23. Clinicopathological diversity and outcome of longitudinal melanonychia in children and adolescents: analysis of 35 cases identified by excision specimens
- Author
-
Yun-Yi Kong, Jing Ren, Min Ren, Jiaojie Lv, Xu Cai, and Jin-Cheng Kong
- Subjects
Male ,0301 basic medicine ,medicine.medical_specialty ,Skin Neoplasms ,Histology ,Adolescent ,Pathology and Forensic Medicine ,Nail Diseases ,03 medical and health sciences ,0302 clinical medicine ,Humans ,Medicine ,Nevus ,Nuclear atypia ,Child ,Longitudinal melanonychia ,Lentigo ,Nevus, Pigmented ,business.industry ,Melanoma ,Incidence (epidemiology) ,Infant ,General Medicine ,medicine.disease ,Dermatology ,030104 developmental biology ,Melanonychia ,Child, Preschool ,030220 oncology & carcinogenesis ,Pagetoid ,Melanocytes ,Female ,business - Abstract
Longitudinal melanonychia in paediatric patients often represents a difficult diagnostic challenge, and studies emphasising its clinical and histopathological features are limited due to its low incidence in childhood.We retrospectively analysed 35 paediatric cases identified by excision specimens on their clinicopathological features, and performed fluorescence in-situ hybridisation on 13 available cases. Fingernails (77.1%) were more likely to be affected. Total melanonychia and Hutchinson's sign were observed in 10 (28.6%) and 14 (40.0%) cases, respectively. Nail dystrophy at diagnosis was present in five cases. After complete excision of the lesions, four patients relapsed during follow-up (mean = 38 months). Seventeen cases were diagnosed as lentigines and 18 as naevi, among which 11 cases were categorised as lentigines/naevi with atypical melanocytic hyperplasia. Mild-to-moderate nuclear atypia, confluency of melanocytes, focal pagetoid spread and peri-ungual skin involvement were found in 25.7% (9 of 35), 40.0% (14 of 35), 40.0% (14 of 35) and 40.0% (14 of 35) of cases, respectively. Thirteen cases tested by fluorescence in-situ hybridisation showed no copy number aberration at the probed loci. There was a statistically significant difference in the following features between patients aged less and more than 10 years (P 0.05): cytomorphology, mild-to-moderate nuclear atypia, confluency of melanocytes, focal pagetoid spread and melanocyte count.Some concerning clinicopathological characteristics, which are signs indicative of melanoma in adults, are not uncommon in paediatric longitudinal melanonychia, especially in patients aged ≤ 10 years. Owing to the extremely low incidence of melanoma in paediatric longitudinal melanonychia, in most circumstances a more conservative clinical management strategy should be adopted.
- Published
- 2020
24. Uterine artery Doppler velocimetry at mid‐term gestation as a potential predictive factor for the resolution of placenta previa at the end of third trimester of pregnancy
- Author
-
Lijuan Yang, Yu Lu, Min Ren, Yilun Wu, and Fan Huang
- Subjects
Adult ,medicine.medical_specialty ,Pregnancy Trimester, Third ,Placenta Previa ,Ultrasonography, Prenatal ,Umbilical Arteries ,03 medical and health sciences ,0302 clinical medicine ,Predictive Value of Tests ,Pregnancy ,medicine.artery ,medicine ,Humans ,Ultrasonography, Doppler, Color ,Uterine artery ,Retrospective Studies ,Gynecology ,030219 obstetrics & reproductive medicine ,Receiver operating characteristic ,business.industry ,Ultrasound ,Obstetrics and Gynecology ,Retrospective cohort study ,Blood flow ,medicine.disease ,Placenta previa ,Uterine Artery ,ROC Curve ,Case-Control Studies ,Pulsatile Flow ,030220 oncology & carcinogenesis ,Gestation ,Female ,Vascular Resistance ,business - Abstract
AIM The incidence of placenta previa before the third trimester is high. But many cases resolve as pregnancy progresses. Our study was to evaluate the efficacy of uterine artery Doppler velocimetry at mid-term gestation for predicting placenta previa resolution in third trimester. METHODS A single-center retrospective study was done. A study cohort of 504 subjects with placenta-cervix os distance measured both at 22-24 weeks and after 36 weeks of gestation and uterine artery Doppler velocimetry measured at 22-24 weeks of gestation were selected. The subjects were assigned to control group (n = 351), resolving group (n = 89) and placenta previa group (n = 64) according to their diagnosis of placenta previa at mid-term and the end of the third trimester. The averages of the bilateral ratio of uterine artery systolic to end-diastolic maximum blood flow velocity (S/D ratio), pulsatility index (PI) and resistance index (RI) were used for analysis. RESULTS The means of S/D ratio, PI and RI of uterine arteries in the placenta previa group were significantly lower than that in either control group or resolving group. No differences were observed between control group and resolving group. The areas under the receiver operating characteristic curve were 0.7632, 0.7579 and 0.7644 for the means of S/D ratio, PI and RI, respectively (P
- Published
- 2020
25. Real-time imaging of individual virion-triggered cortical actin dynamics for human immunodeficiency virus entry into resting CD4 T cells
- Author
-
Yuntao Wu, Qin Li, Shibo Jiang, Yuanyuan Liu, Min Ren, Ji Liu, Wen Yin, Wei Li, Xiaowei Zhang, Zongqiang Cui, Yingxin Ma, Zhiping Zhang, and Xian-En Zhang
- Subjects
CD4-Positive T-Lymphocytes ,Human immunodeficiency virus (HIV) ,HIV Infections ,Peptide ,macromolecular substances ,02 engineering and technology ,medicine.disease_cause ,Antiviral Agents ,Time-Lapse Imaging ,Virus ,03 medical and health sciences ,Viral entry ,Quantum Dots ,Actin dynamics ,Plasma membrane fusion ,medicine ,Humans ,General Materials Science ,Actin ,Fluorescent Dyes ,030304 developmental biology ,chemistry.chemical_classification ,0303 health sciences ,Chemistry ,Virion ,Virus Internalization ,021001 nanoscience & nanotechnology ,Actin cytoskeleton ,Actins ,Cell biology ,Actin Cytoskeleton ,Microscopy, Fluorescence ,HIV-1 ,Peptides ,0210 nano-technology - Abstract
Real-time imaging of single virus particles allows the visualization of subtle dynamic events of virus-host interaction. During the human immunodeficiency virus (HIV) infection of resting CD4 T lymphocytes, overcoming cortical actin restriction is an essential step, but the dynamic process and mechanism remain to be characterized. Herein, by using quantum dot (QD) encapsulated fluorescent viral particles and single-virus tracking, we explored detailed scenarios of HIV dynamic entry and crossing the cortical actin barrier. The fine-scale temporal and spatial processes of single HIV virion interaction with the cortical actin were studied in depth during virus entry via plasma membrane fusion. Individual HIV virions modulate the subtle rearrangement of the cortical actin barrier to open a door to facilitate viral entry. The actin-binding protein, α-actinin, was found to be critical for actin dynamics during HIV entry. An α-actinin-derived peptide, actin-binding site 1 peptide (ABS1p), was developed to block HIV infection. Our findings reveal an α-actinin-mediated dynamic cortical actin rearrangement for HIV entry, and identify an antiviral target as well as a corresponding peptide inhibitor based on HIV interaction with the actin cytoskeleton.
- Published
- 2020
26. A phase 2 study of lenvatinib in patients with RET fusion-positive lung adenocarcinoma
- Author
-
Pallavi Sachdev, Hiroshi Nokihara, Karen L. Reckamp, Tomohide Tamura, Corina E. Dutcus, Takuya Nakada, Toyoaki Hida, Min Ren, Tomoki Kubota, and Vamsidhar Velcheti
- Subjects
Adult ,Male ,0301 basic medicine ,Pulmonary and Respiratory Medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,Lung Neoplasms ,Oncogene Proteins, Fusion ,Phases of clinical research ,Adenocarcinoma of Lung ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Internal medicine ,Clinical endpoint ,medicine ,Humans ,Molecular Targeted Therapy ,Adverse effect ,Protein Kinase Inhibitors ,Aged ,business.industry ,Phenylurea Compounds ,Proto-Oncogene Proteins c-ret ,Middle Aged ,medicine.disease ,Survival Rate ,030104 developmental biology ,chemistry ,Tolerability ,Response Evaluation Criteria in Solid Tumors ,RET Fusion Positive ,030220 oncology & carcinogenesis ,Quinolines ,Adenocarcinoma ,Female ,Lenvatinib ,business - Abstract
Objectives Despite improved outcomes associated with immunotherapies for non-small cell lung cancer (NSCLC), many patients do not respond to treatment. Therefore, there is still an unmet need for molecularly targeted therapies in this patient population. Fusions of the RET oncogene have been identified as driver alterations in patients with NSCLC. Lenvatinib is a multityrosine kinase inhibitor of vascular endothelial growth factor receptors 1–3, fibroblast growth factor receptors 1–4, RET, and other targets. This study evaluated the safety and efficacy of lenvatinib in patients with RET fusion-positive lung adenocarcinoma. Materials and methods In this phase 2, multicenter, open-label study (NCT01877083), patients with RET-positive lung adenocarcinoma received oral lenvatinib 24 mg/day. The primary end point was objective response rate (ORR) by investigator review per Response Evaluation Criteria In Solid Tumors v1.1 criteria. The secondary end points included safety and tolerability, progression-free survival (PFS), and overall survival (OS). Results Of 536 patients who screened for study inclusion and exclusion, 25 patients with RET translocations (KIF5B-RET [n = 13] and CCDC6-RET [n = 12]) were identified and received lenvatinib. The overall ORR was 16% (95% CI: 4.5%–36.1%). At data cutoff (February 3, 2016), the median PFS was 7.3 months (95% CI: 3.6–10.2) and the median OS was not reached. Duration of response was not estimable at the time of data cutoff. All patients experienced a treatment-emergent adverse event (TEAE); 23 (92%) patients experienced a TEAE of ≥ grade 3, and 6 (24%) patients discontinued lenvatinib due to a TEAE. The most common TEAEs were hypertension (68%), nausea (60%), decreased appetite (52%), diarrhea (52%), and proteinuria (48%). Conclusions Lenvatinib demonstrated activity in patients with RET fusion-positive lung adenocarcinomas; although the response rate was relatively low, the median PFS supports the activity of lenvatinib in these patients.
- Published
- 2019
27. Theoretical study and application of 2-phenyl-1,3,4-thiadiazole derivatives with optical and inhibitory activity against SHP1
- Author
-
Xuehui Guo, Bo Feng, Ai-Min Ren, Jia Li, Gao Lixin, Wen-Long Wang, Chun Zhang, Yu-Bo Zhou, Xue Yan, and Yitao Sun
- Subjects
chemistry.chemical_classification ,Fluorescence-lifetime imaging microscopy ,biology ,Molecular Structure ,Chemistry ,Protein Tyrosine Phosphatase, Non-Receptor Type 6 ,General Physics and Astronomy ,Quantum yield ,Protein tyrosine phosphatase ,biology.organism_classification ,Fluorescence ,HeLa ,Enzyme ,Thiadiazoles ,Biophysics ,Molecule ,Humans ,Physical and Theoretical Chemistry ,Enzyme Inhibitors ,Density Functional Theory ,Proto-oncogene tyrosine-protein kinase Src ,HeLa Cells - Abstract
As one member of PTPs, Src homology-2 domain-containing protein tyrosine phosphatase 1 (SHP1) is mainly restricted to hematopoietic and epithelial cells and widely accepted as a convergent node for oncogenic cell-signaling cascades. Developing efficient methods for rapidly tracing and inhibiting the SHP1 activity in complex biological systems is of considerable significance for advancing the integration of diagnosis and treatment of related disease. On this goal, we designed and synthesized five 2-phenyl-1,3,4-thiadiazole derivatives (PT2, PT5, PT8, PT9 and PT10) here basing on the reported SHP1 inhibitors (PT1, PT3, PT4, PT6 and PT7) with planarity structure. The photophysical properties and inhibitory activities of these 2-phenyl-1,3,4-thiadiazole derivatives (PT1 ‒ PT10) for SHP1 were thoroughly studied from theoretical aspect and experimental application. The representative compound PT10 exhibited the larger quantum yield than the other molecules because of smaller geometric relaxation and reorganization energy of the excited state, which was consistent with the results from the fluorescence experiments in organic solvent. In addition, PT10 showed selectively fluorescence response for SHP1 activity and low-cytotoxicity on Hela cells. Lastly, it indicated the potential application in two-photon cell fluorescence imaging in the future according to the calculated excellent two-photon absorption properties. In this contribution, we offered the fluorescent and activated molecule PT10 against SHP1 firstly, which achieved the integration of visualization and inhibitory activity of SHP1 preliminarily in enzyme molecular level.
- Published
- 2021
28. A comparative analysis of diagnostic values of high-frequency ultrasound and fiberoptic ductoscopy for pathologic nipple discharge
- Author
-
Hongmei Yuan, Xuemei Tang, Xurong Mou, Yuhong Fan, Xiang Yan, Jinsui Li, Lingmi Hou, and Min Ren
- Subjects
Nipples ,Nipple Discharge ,Fiber Optic Technology ,Humans ,Radiology, Nuclear Medicine and imaging ,Breast Neoplasms ,Endoscopy ,Female ,Ultrasonography - Abstract
Background This study aimed to compare the diagnostic accuracy of high-frequency ultrasound (HFUS) and fiberoptic ductoscopy (FDS) for pathologic nipple discharge (PND). Methods HFUS and FDS were conducted in 210 patients with PND (248 lesions) treated at our hospital. The diagnostic accuracy of these two methods was compared using pathological diagnosis as the standard. Results Among 248 lesions, 16 and 15 of 16 malignant lesions were accurately diagnosed by HFUS and FDS, respectively. Of 232 benign lesions, 183 and 196 cases were accurately diagnosed by HFUS and FDS, respectively. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of HFUS in diagnosis of intraductal lesions were 84.36% (95% CI 79.26–88.39%), 60% (95% CI 23.07–92.89%), 96.03% (95% CI 96.55–99.83%), and 7.31% (95% CI 2.52–19.4%) respectively. The sensitivity, specificity, PPV, and NPV of FDS in diagnosis of intraductal lesions were 86.83% (95% CI 82.00–90.52%), 100% (95% CI 56.55–100%), 100% (95% CI 98.21–100%), and 13.51% (95% CI 5.91–27.98%) respectively. Diagnostic accuracy rates of HFUS and FDS were 83.87% (208/248) and 85.08% (211/248), respectively, exhibiting no statistically differences (χ2 = 0.80, P > 0.05). The accuracy of HFUS combined with FDS was 93.14% (231/248), showing statistically differences (χ2 = 10.91, P Conclusions Both HFUS and FDS demonstrated high diagnostic values for PND. HFUS has the advantage of non-invasive for nipple discharge with duct ectasia, exhibited good qualitative and localization diagnostic values. It is the preferred evaluation method for patients with nipple discharge. When HFUS cannot identify the cause of PND, FDS can be considered.
- Published
- 2021
29. Phase 1 study of the liposomal formulation of eribulin (E7389-LF): Results from the breast cancer expansion cohort
- Author
-
Norikazu Masuda, Makiko Ono, Toru Mukohara, Hiroyuki Yasojima, Tatsunori Shimoi, Kokoro Kobayashi, Kenichi Harano, Makiko Mizutani, Maki Tanioka, Shunji Takahashi, Takahiro Kogawa, Takuya Suzuki, Shiori Okumura, Takao Takase, Reiko Nagai, Taro Semba, Zi-Ming Zhao, Min Ren, and Kan Yonemori
- Subjects
Cohort Studies ,Cancer Research ,Oncology ,Drug Compounding ,Liposomes ,Humans ,Breast Neoplasms ,Female ,Triple Negative Breast Neoplasms ,Ketones ,Furans ,Febrile Neutropenia - Abstract
A liposomal formulation of eribulin, E7389-LF, may provide improved pharmacokinetics and allow increased access to tumour tissues. This expansion of a phase 1 study assessed the safety and efficacy of E7389-LF in patients with human epidermal growth factor receptor type 2-negative metastatic breast cancer.Patients received E7389-LF 2.0 mg/mOf 28 patients included, 75.0% had hormone receptor-positive breast cancer (HR+ BC) and 25.0% had triple-negative breast cancer (TNBC). The most common grade ≥3 treatment-related treatment-emergent adverse events included neutropenia (67.9%), leukopenia (42.9%), thrombocytopenia (32.1%), and febrile neutropenia (25.0%). Rates of neutropenia and febrile neutropenia were lower among patients who received prophylactic pegfilgrastim. Objective response rate was 35.7% (95% confidence interval [CI]: 18.6-55.9) for all patients and 42.9% (95% CI: 21.8-66.0) for patients with HR+ BC. Median progression-free survival was 5.7 months (95% CI: 3.9-8.3). The median overall survival was 18.3 months (95% CI: 13.2-not estimable). Among the 54 biomarkers assessed, 27, including 5 of 7 vascular markers, were significantly altered by E7389-LF treatment from baseline to any time point.E7389-LF was tolerable and favourable antitumour activity was observed, particularly in patients with HR+ BC. Prophylactic pegfilgrastim can be considered in patients at high risk for neutropenia and febrile neutropenia.NCT03207672.
- Published
- 2021
30. Targeted Nanotherapeutics Using LACTB Gene Therapy Against Melanoma
- Author
-
Jinlu Liu, Min Ren, Meimei Xiong, Maling Gou, Xuewen Xu, Xin Yuan, Jianlin Long, Ling Yang, Wenbi Wu, and Jiao Zhu
- Subjects
Tumor suppressor gene ,Genetic enhancement ,Cell ,Melanoma, Experimental ,Biophysics ,LACTB ,Pharmaceutical Science ,Antineoplastic Agents ,Apoptosis ,Bioengineering ,Biology ,beta-Lactamases ,Mitochondrial Proteins ,Biomaterials ,Mice ,In vivo ,International Journal of Nanomedicine ,Cell Line, Tumor ,Drug Discovery ,melanoma ,medicine ,Animals ,Humans ,nanocomplexes ,neoplasms ,Original Research ,Melanoma ,Organic Chemistry ,Membrane Proteins ,Genetic Therapy ,General Medicine ,Cell cycle ,medicine.disease ,gene therapy ,Mice, Inbred C57BL ,medicine.anatomical_structure ,Cell culture ,Cancer research ,Nanoparticles - Abstract
Jinlu Liu,1,* Ling Yang,1,* Xin Yuan,2,* Meimei Xiong,1 Jiao Zhu,1 Wenbi Wu,1 Min Ren,1 Jianlin Long,3 Xuewen Xu,2 Maling Gou1 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, Peopleâs Republic of China; 2Department of Plastic and Burn Surgery, West China Hospital of Sichuan University, Chengdu, 610041, Peopleâs Republic of China; 3Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, 400030, Peopleâs Republic of China*These authors contributed equally to this workCorrespondence: Maling GouState Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, 610041, Peopleâs Republic of ChinaEmail goumaling@scu.edu.cnXuewen XuDepartment of Plastic and Burn Surgery, West China Hospital of Sichuan University, Chengdu, 610041, Peopleâs Republic of ChinaEmail xxw_0826@163.comIntroduction: β-lactamase (LACTB) is a tumor suppressor gene in various tumors including melanoma. However, it remains challenging to efficiently deliver the LACTB gene into melanoma. Recently, we designed a nonviral nanocarrier iRGD/DOTAP/MPEG-PDLLA (iDPP) that could deliver gene targetedly to melanoma efficiently without obvious adverse effects.Methods: In this study, the tumor-targeted nanoparticle iDPP was prepared to deliver LACTB gene to treat melanoma in vitro and in vivo. First, the expression level of LACTB in 6 clinical specimens of melanoma patients was evaluated. Subsequently, the characteristics of iDPP/LACTB nanocomplexes were studied. Afterwards, the in vitro and in vivo anti-tumor efficacy of the iDPP/LACTB nanocomplexes were explored utilizing the B16-F10 mouse melanoma cell line and the B16-F10 subcutaneous melanoma model.Results: Compared with the normal epithelium, the expression level of LACTB in melanoma tissues was significantly downregulated. In vitro B16-F10 cell tests showed iDPP/LACTB nanocomplexes could increase the mRNA levels of P21, Bid, Bax, Pidd1, and Sival genes and up-regulate the p53 signaling pathway of melanoma cells, thus promoting cell apoptosis and blocking the cell cycle. Injected intravenously, iDPP nanoparticles could deliver DNA to the subcutaneous melanoma targetedly. Based on in vivo mouse xenograft model, iDPP/LACTB nanocomplexes could effectively inhibit tumor proliferation and induce tumor apoptosis, thus significantly inhibiting melanoma growth (tumor inhibition rate is about 68%) in the subcutaneous B16-F10 melanoma model.Conclusion: The downregulated LACTB might be a potential target for melanoma therapy. The iDPP/LACTB nanocomplexes could inhibit the growth of the mouse melanoma without obvious side effects, which provide a new option for melanoma gene therapy research.Keywords: melanoma, LACTB, nanocomplexes, gene therapy
- Published
- 2021
31. In vivo evaluation of facial papule dermatoses with reflectance confocal microscopy in children
- Author
-
Lixin Chen, Ying Wang, Xibo Gao, Bei Qin, Jia Lian, Min Ren, Wanxing Zhang, Ran Wei, and Qinfeng Li
- Subjects
Diagnosis, Differential ,Microscopy, Confocal ,Skin Neoplasms ,Humans ,Dermoscopy ,Dermatology ,Warts ,Child ,Keratosis, Seborrheic ,Facial Dermatoses - Abstract
Molluscum contagiosum (MC), milia, keratosis pilaris (KP), verruca plana (VP), seborrheic keratosis (SK), and juvenile xanthogranuloma (JXG) are common papule dermatoses on the face of children that have a similar appearance. In vivo evaluation of facial papule dermatoses with reflectance confocal microscopy (RCM) is helpful in the diagnosis of these ambiguous lesions in children. The purpose of this study was to clarify the RCM characteristics of MC, milia, KP, VP, SK, and JXG and explore the clinical application value of RCM for these common facial papule dermatoses.We recruited 113 patients referred for unequivocal facial papule dermatosis, including 21 patients with MC, 17 patients with milia, 19 patients with KP, 36 patients with VP, 8 patients with SK, and 12 patients with JXG. We evaluated the characteristics and distinguishing features of the six kinds of facial papule dermatoses using RCM.The main RCM features of the six dermatoses included a well-demarcated border of the lesion area. MC, milia and KP all manifested cyst-like structures, and their distinguishing features were the location of the cystic structures and the refractive index of the contents. Although VP, SK, and JXG did not have obvious cystoid structures, VP was typically characterized by uniformly distributed petal-like structures with a medium-to-high refractive index in the epidermis. With regard to SK, the characteristic features were an obviously thickened epidermis and cobblestone-like structures. JXG was mainly characterized by multiple large round and ovoid cells with a foamy cytoplasm, and discoid-shaped multinucleated large cells were diffusely distributed in the dermis.RCM allows the real-time visualization of major key diagnostic and distinguishing features of common facial papule dermatoses in children, including MC, milia, KP, VP, SK, and JXG.
- Published
- 2021
32. Dose Escalation Data from the Phase 1 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Japanese Patients with Advanced Solid Tumors
- Author
-
Jun Sato, Toshio Shimizu, Takafumi Koyama, Satoru Iwasa, Akihiko Shimomura, Shunsuke Kondo, Shigehisa Kitano, Kan Yonemori, Yutaka Fujiwara, Kenji Tamura, Takuya Suzuki, Takao Takase, Reiko Nagai, Kohei Yamaguchi, Taro Semba, Zi-Ming Zhao, Min Ren, and Noboru Yamamoto
- Subjects
Adult ,Vascular Endothelial Growth Factor A ,Cancer Research ,Dose-Response Relationship, Drug ,Maximum Tolerated Dose ,Ketones ,Ligands ,Young Adult ,Oncology ,Japan ,Neoplasms ,Antineoplastic Combined Chemotherapy Protocols ,Liposomes ,Humans ,Chemokines ,Furans ,Biomarkers - Abstract
Purpose: We report the dose-escalation part of a phase I study of liposomal eribulin (E7389-LF) in Japanese patients with advanced solid tumors and no alternative standard therapy. Patients and Methods: Patients ≥20 years old were enrolled. E7389-LF doses of 1.0 to 1.5 mg/m2 once every two weeks (Q2W) or 1.0 to 2.5 mg/m2 once every three weeks (Q3W) were planned. The primary objective was to determine the MTD by evaluating dose-limiting toxicities (DLT). Secondary objectives included safety/tolerability assessments, objective response rate (ORR), and progression-free survival; serum biomarker assessment was an exploratory objective. Results: Twenty-one patients were enrolled and treated; 12 in the Q3W group (1.0 mg/m2, n = 3; 1.5 mg/m2, n = 3; 2.0 mg/m2, n = 6) and 9 in the Q2W group (1.0 mg/m2, n=3; 1.5 mg/m2, n = 6). The Q3W and Q2W MTDs were 2.0 mg/m2 and 1.5 mg/m2, respectively. One patient receiving 2.0 mg/m2 Q3W had a DLT of grade 3 febrile neutropenia. The most common grade 3 treatment-emergent adverse events were neutropenia (66.7% in Q3W and Q2W) and leukopenia (Q3W, 58.3%; Q2W, 33.3%). One patient in the Q3W group (2.0 mg/m2) and 3 in the Q2W group (1.0 mg/m2, n = 1; 1.5 mg/m2, n = 2) achieved a partial response [overall ORR, 19.0%; 95% confidence interval (CI), 5.4–41.9]. Endothelial [TEK receptor tyrosine kinase (TEK), intercellular adhesion molecule 1 (ICAM1), vascular endothelial growth factor receptor 3 (VEGFR3), platelet/endothelial cell adhesion molecule 1 (PECAM1)], vasculature (collagen IV), and immune-related [interferon gamma (IFNγ), C-X-C motif chemokine ligand 11 (CXCL11), C-X-C motif chemokine ligand 10 (CXCL10)] biomarker levels were increased. Conclusions: E7389-LF was well tolerated at 2.0 mg/m2 Q3W and 1.5 mg/m2 Q2W. Considering the toxicity profile of both regimens, the recommended dose was 2.0 mg/m2 Q3W. Expansion cohorts are ongoing.
- Published
- 2021
33. Theoretical Study of a Two-Photon Fluorescent Probe Based on Nile Red Derivatives with Controllable Fluorescence Wavelength and Water Solubility
- Author
-
Jing-Fu Guo, Li-Ying Yu, Li-Bo Yu, Ai-Min Ren, Wei-bo Cui, Xue-hui Guo, Ze-xing Qu, Xue Wei, Teng-Fei He, and Xue-Li Hao
- Subjects
Aqueous solution ,General Chemical Engineering ,Nile red ,Quantum yield ,Chemical modification ,Water ,General Chemistry ,Library and Information Sciences ,Models, Theoretical ,Fluorescence ,Computer Science Applications ,chemistry.chemical_compound ,chemistry ,Two-photon excitation microscopy ,Solubility ,Oxazines ,Biophysics ,Humans ,Absorption (electromagnetic radiation) ,Fluorescent Dyes - Abstract
Hypochloric acid (HOCl) plays a vital role in the natural defense system, but abnormal levels of it can cause cell damage, accelerated human aging, and various diseases. It is of great significance to develop new probes for detecting HOCl in biosystems nondestructively and noninvasively. The purpose of this work is to explore new chemical modification strategies of two-photon excitation fluorescence (TPEF) probes to improve the poor water solubility and low efficiency in imaging applications. Nil-OH-6 has a two-photon absorption cross-section value as high as 243 GM and attains a good quantum yield of 0.49. In addition, the modification of terminal groups with different azetidine-heterospirocycles or N,N-dialkyl fused amino groups to Nile Red can effectively improve the fluorescence efficiency as well as increase the solubility to some extent. This study provides some strategies to simultaneously improve the fluorescence performance and solubility of these two-photon probes and, hence, reliable guidance and a foundation for the subsequent synthesis of TPEF probes based on Nile Red.
- Published
- 2021
34. Aberrant expression of long non-coding RNAs in peripheral blood mononuclear cells response to tuberculosis in children
- Author
-
Xiaoling, Zhong, Shikun, Lei, Jing-Wen, Lin, Min, Ren, and Min, Shu
- Subjects
Latent Tuberculosis ,Heterochromatin ,Gene Expression Profiling ,Leukocytes, Mononuclear ,Humans ,Tuberculosis ,RNA, Long Noncoding ,RNA, Messenger ,General Medicine ,Child ,DNA, Ribosomal ,Biomarkers - Abstract
We aimed to identify long non-coding RNAs (lncRNAs) aberrantly expressed in peripheral blood mononuclear cells (PBMCs) triggered by active tuberculosis (ATB), latent tuberculosis infection (LTBI), and healthy controls (HC). We examined lncRNAs expression in PBMCs isolated from children with ATB and LTBI, and from HC using RNA sequencing. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were used to explore the biological processes and signaling pathways of aberrantly expressed mRNAs. A total of 348 and 205 lncRNAs were differentially expressed in the ATB and LTBI groups, respectively, compared to the HC group. Compared to the LTBI group, 125 lncRNAs were differentially expressed in the ATB group. Compared to the HC group, 2317 mRNAs were differentially expressed in the ATB group, and 1093 mRNAs were differentially expressed in the LTBI group. Compared to the LTBI group, 2328 mRNAs were differentially expressed in the ATB group. The upregulated mRNAs were mainly enriched in neutrophil activation, neutrophil-mediated biological processes, and positive regulation of immune response in tuberculosis (TB), whereas the downregulated mRNAs were enriched in signaling pathways and structural processes, such as the Wnt signaling pathway and rDNA heterochromatin assembly. This is the first study on the differential expression of lncRNAs in PBMCs of children with TB. We identified significant differences in the expression profiles of lncRNAs and mRNAs in the PBMCs of children with ATB, LTBI, and HC, which has important implications for exploring lncRNAs as novel biomarkers for the diagnosis of TB. In addition, further experimental identification and validation of lncRNA roles could help elucidate the underlying mechanisms of Mycobacterium tuberculosis infection in children.
- Published
- 2022
35. Primary cutaneous adenoid cystic carcinoma: a clinicopathologic, immunohistochemical, and fluorescence in-situ hybridisation study of 13 cases
- Author
-
J. Hu, Jin-Cheng Kong, Min Ren, Jiaojie Lv, Xu Cai, and Yun-Yi Kong
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Histology ,Necrosis ,Skin Neoplasms ,Primary cutaneous adenoid cystic carcinoma ,Pathology and Forensic Medicine ,Lesion ,medicine ,Humans ,MYB ,In Situ Hybridization, Fluorescence ,Aged ,Retrospective Studies ,medicine.diagnostic_test ,business.industry ,Myoepithelial cell ,General Medicine ,Middle Aged ,medicine.disease ,Carcinoma, Adenoid Cystic ,medicine.anatomical_structure ,Scalp ,Immunohistochemistry ,Female ,medicine.symptom ,business ,Fluorescence in situ hybridization - Abstract
AIMS This study aimed to investigate the clinical, histological, immunohistochemical and chromosomal features of primary cutaneous adenoid cystic carcinoma (PCACC). METHODS AND RESULTS We retrospectively analysed 13 cases identified on their clinicopathological features and performed fluorescence in-situ hybridisation (FISH) on six available cases. Head and neck (46.2%) were most commonly involved. The median age was 53 years, with a male predilection. Histologically, tumours were classified as grades 1 (eight), 2 (four) and 3 with high-grade transformation (HGT) (one). The HGT component was demonstrated as poorly differentiated carcinoma with multifocal necrosis and myoepithelial differentiation. Patients with one of the following factors: longest diameter of the lesion (≥ 1 cm), involvement of subcutaneous fat tissue and widely infiltrative border had a relatively higher rate of local recurrence, distant metastasis and death. Five of six cases were confirmed to have MYB translocation, while nuclear staining for MYB proto-oncogene, transcription factor (MYB) protein was found in four cases. During the follow-up (median = 64 months), two patients experienced local recurrences. One patient, who was classified as grade III PCACC with HGT, developed multiple metastases and died of disease. Another patient was alive with multiple metastases. CONCLUSIONS This is the largest single-institution study, to our knowledge, of PCACC in an Asian population. We describe the first case of scalp PCACC with HGT, which is the only death case in our series. PCACC tends to recur locally and has metastatic potential. PCACC with HGT has a poor prognosis.
- Published
- 2021
36. Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study
- Author
-
Yasuhiro Funahashi, Hiroki Ikezawa, Lucjan Wyrwicz, Richard S. Finn, Masatoshi Kudo, Shukui Qin, Min Ren, Thomas R. Jeffry Evans, Ari David Baron, Roger K.C. Ngan, Yukinori Minoshima, Fabio Piscaglia, Ann-Lii Cheng, Masafumi Ikeda, Arndt Vogel, Corina E. Dutcus, Jean-Frédéric Blanc, R. Dairiki, Toshiyuki Tamai, Kwang Hyub Han, Michio Kanekiyo, Finn R.S., Kudo M., Cheng A.-L., Wyrwicz L., Ngan R.K.C., Blanc J.-F., Baron A.D., Vogel A., Ikeda M., Piscaglia F., Han K.-H., Qin S., Minoshima Y., Kanekiyo M., Ren M., Dairiki R., Tamai T., Dutcus C.E., Ikezawa H., Funahashi Y., and Evans T.R.J.
- Subjects
0301 basic medicine ,Oncology ,Sorafenib ,Cancer Research ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Clinical Trials and Supportive Activities ,Oncology and Carcinogenesis ,Antineoplastic Agents ,lenvatinib ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Text mining ,Rare Diseases ,Predictive Value of Tests ,Clinical Research ,Internal medicine ,medicine ,Biomarkers, Tumor ,Humans ,Oncology & Carcinogenesis ,Cancer ,Tumor ,business.industry ,Phenylurea Compounds ,Carcinoma ,Liver Neoplasms ,FGF19 ,Hepatocellular ,hepatocellular carcinoma ,medicine.disease ,Confidence interval ,Survival Rate ,030104 developmental biology ,chemistry ,030220 oncology & carcinogenesis ,Pharmacodynamics ,Hepatocellular carcinoma ,Quinolines ,Biomarker (medicine) ,Lenvatinib ,business ,Biomarkers ,medicine.drug - Abstract
Purpose: In REFLECT, lenvatinib demonstrated an effect on overall survival (OS) by confirmation of noninferiority to sorafenib in unresectable hepatocellular carcinoma. This analysis assessed correlations between serum or tissue biomarkers and efficacy outcomes from REFLECT. Experimental Design: Serum biomarkers (VEGF, ANG2, FGF19, FGF21, and FGF23) were measured by ELISA. Gene expression in tumor tissues was measured by the nCounter PanCancer Pathways Panel. Pharmacodynamic changes in serum biomarker levels from baseline, and associations of clinical outcomes with baseline biomarker levels, were evaluated. Results: Four hundred and seven patients were included in the serum analysis set (lenvatinib n = 279, sorafenib n = 128); 58 patients were included in the gene-expression analysis set (lenvatinib n = 34, sorafenib n = 24). Both treatments were associated with increases in VEGF; only lenvatinib was associated with increases in FGF19 and FGF23 at all time points. Lenvatinib-treated responders had greater increases in FGF19 and FGF23 versus nonresponders at cycle 4, day 1 (FGF19: 55.2% vs. 18.3%, P = 0.014; FGF23: 48.4% vs. 16.4%, P = 0.0022, respectively). Higher baseline VEGF, ANG2, and FGF21 correlated with shorter OS in both treatment groups. OS was longer for lenvatinib than sorafenib [median, 10.9 vs. 6.8 months, respectively; HR, 0.53; 95% confidence interval (CI), 0.33–0.85; P-interaction = 0.0397] with higher baseline FGF21. In tumor tissue biomarker analysis, VEGF/FGF-enriched groups showed improved OS with lenvatinib versus the intermediate VEGF/FGF group (HR, 0.39; 95% CI, 0.16–0.91; P = 0.0253). Conclusions: Higher baseline levels of VEGF, FGF21, and ANG2 may be prognostic for shorter OS. Higher baseline FGF21 may be predictive for longer OS with lenvatinib compared with sorafenib, but this needs confirmation.
- Published
- 2021
37. Rabies Virus Neutralizing Activity, Safety, and Immunogenicity of Recombinant Human Rabies Antibody Compared with Human Rabies Immunoglobulin in Healthy Adults
- Author
-
Jun Nan, Zhang, Ya Juan, Meng, Yun Hua, Bai, Yu Feng, Li, Li Qing, Yang, Nian Min, Shi, Hui Xia, Han, Jian, Gao, Li Juan, Zhu, Shu Ping, Li, Jing, Zhang, Qin Hua, Zhao, Xiu Qin, Wang, Jing Shuang, Wei, Le Min, Ren, Chen Hua, Cao, Chen, Chen, Wei, Zhao, and Li, Li
- Subjects
Adult ,Rabies Vaccines ,Rabies ,Rabies virus ,Data Collection ,Humans ,Antibodies, Viral ,Antibodies, Neutralizing - Abstract
Preliminary assessment of rabies virus neutralizing activity, safety and immunogenicity of a recombinant human rabies antibody (NM57) compared with human rabies immunoglobulin (HRIG) in Chinese healthy adults.Subjects were randomly (1:1:1) allocated to Groups A (20 IU/kg NM57), B (40 IU/kg NM57), or C (20 IU/kg HRIG). One injection was given on the day of enrollment. Blood samples were collected on days -7 to 0 (pre-injection), 3, 7, 14, 28, and 42. Adverse events (AEs) and serious AEs (SAEs) were recorded over a period of 42 days after injection.All 60 subjects developed detectable rabies virus neutralizing antibodies (RVNAs) (0.05 IU/mL) on days 3, 7, 14, 28, and 42. The RVNA levels peaked on day 3 in all three groups, with a geometric mean concentration (GMC) of 0.2139 IU/mL in Group A, 0.3660 IU/mL in Group B, and 0.1994 IU/mL in Group C. At each follow-up point, the GMC in Group B was significantly higher than that in Groups A and C. The areas under the antibody concentration curve over 0-14 days and 0-42 days in Group B were significantly larger than those in Groups A and C. Fifteen AEs were reported. Except for one grade 2 myalgia in Group C, the other 14 were all grade 1. No SAEs were observed.The rabies virus neutralizing activity of 40 IU/kg NM57 was superior to that of 20 IU/kg NM57 and 20 IU/kg HRIG, and the rabies virus neutralizing activity of 20 IU/kg NM57 and 20 IU/kg HRIG were similar. Safety was comparable between NM57 and HRIG.
- Published
- 2021
38. Association between thyroid hormone levels and frailty in an older inpatient cohort: a cross-sectional study
- Author
-
Min Ren, Min Zhang, Yang Liu, Qin Sun, Ting Liang, and Ping Chen
- Subjects
medicine.medical_specialty ,China ,Thyroid Hormones ,Activities of daily living ,Cross-sectional study ,Frail Elderly ,Thyroid Gland ,Internal medicine ,Activities of Daily Living ,Medicine ,Humans ,Aged ,Advanced and Specialized Nursing ,Geriatrics ,Inpatients ,Frailty ,business.industry ,Odds ratio ,Anesthesiology and Pain Medicine ,Cross-Sectional Studies ,Cohort ,Population study ,Thyroid function ,business ,human activities ,Body mass index - Abstract
BACKGROUND Frailty is a common biological syndrome in elderly people, and the aging process regulates thyroid function. The present study aimed to determine the prevalence of frailty in an older inpatient cohort using the FRAIL scale and to evaluate the association of frailty with thyroid hormone levels. METHODS This cross-sectional study was performed in the Department of Geriatrics, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China. From November 2019 to April 2020, 146 inpatients aged ≥65 years were recruited for the study and demographic data, frailty, geriatric assessment, and thyroid hormone levels were evaluated. Frailty was determined by the FRAIL scale, and geriatric assessment was based on activities of daily living (ADL) and instrumental activities of daily living (IADL). The data were analyzed using appropriate parametric and nonparametric statistical tests. RESULTS At enrollment, 31 (21.23%) of the total participants were robust, 31 (21.23%) were pre-frail, and 84 (57.53%) were frail. The frail patients were significantly older than the robust patients and pre-frail patients (P
- Published
- 2021
39. A Meta-analysis of Traffic-related Air Pollution and Risk of Childhood Leukemia
- Author
-
Min-Min Ren, Zeng-Hong Gong, Jian Li, Yan Yu, Xiao-Yong Wang, and Jian Zhou
- Subjects
Male ,Traffic-Related Pollution ,medicine.medical_specialty ,Adolescent ,Childhood leukemia ,MEDLINE ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Jian Zhou ,Humans ,Medicine ,Child ,Leukemia ,business.industry ,Incidence ,Incidence (epidemiology) ,Case-control study ,Infant ,Hematology ,Odds ratio ,medicine.disease ,Confidence interval ,Oncology ,Case-Control Studies ,Child, Preschool ,030220 oncology & carcinogenesis ,Meta-analysis ,Pediatrics, Perinatology and Child Health ,Female ,business ,030215 immunology - Abstract
Background Many studies have analyzed the association between traffic-related air pollution and risk of childhood leukemia, but the results are inconsistent. Therefore, we performed this meta-analysis to investigate the association between traffic-related air pollution and risk of childhood leukemia. Methods PubMed, Cochrane, and Embase databases were searched by the index words to identify eligible case-control studies, and relevant literature sources were also searched. The latest research was performed in September 2017. Odds ratio (OR) along with 95% confidence interval (95% CI) were used to analyzed the main outcomes. Results Twenty-one case-control studies were included in the meta-analysis. The results indicated that in the studies of overall traffic density (OR: 1.01, 95% CI: 0.98-1.04), high traffic density (OR: 1.04, 95% CI: 0.91-1.17), moderate exposure to NO2 (OR: 1.02, 95% CI: 0.93-1.10), and benzene (OR: 1.04, 95% CI: 0.71-1.37), the risks of childhood leukemia incidence were higher in the case group than the control group, but no significant difference was found. In other analysis, no significant difference was observed in the risk of childhood leukemia in the 2 groups. Conclusions Current evidence suggests that childhood leukemia is associated with traffic density, and moderate exposure to NO2 and benzene. However, more high-quality studies are required to confirm the conclusions.
- Published
- 2019
40. Identification of recurrent and novel mutations by whole-genome sequencing of colorectal tumors from the Han population in Shanghai, eastern China
- Author
-
Shouxin Wu, Hongfei Teng, Xun Jiang, Nan Qin, Ning Li, Min Ren, Renyuan Gao, Huanlong Qin, Jiangman Zhao, and Yu Wang
- Subjects
0301 basic medicine ,Adult ,Male ,Cancer Research ,chromosomal rearrangement ,China ,DNA Copy Number Variations ,Colorectal cancer ,DNA Mutational Analysis ,colorectal cancer ,Biology ,Biochemistry ,03 medical and health sciences ,0302 clinical medicine ,Genetics ,medicine ,Humans ,Genetic Predisposition to Disease ,Molecular Biology ,Gene ,Aged ,Neoplasm Staging ,Whole genome sequencing ,Aged, 80 and over ,Oncogene ,Whole Genome Sequencing ,copy number variation ,Chromosome ,Computational Biology ,Articles ,Middle Aged ,medicine.disease ,Fusion protein ,Molecular medicine ,digestive system diseases ,030104 developmental biology ,Oncology ,whole-genome sequencing ,030220 oncology & carcinogenesis ,Population Surveillance ,Mutation ,Molecular Medicine ,Female ,Chromosome 20 ,Colorectal Neoplasms ,Genome-Wide Association Study - Abstract
Previous studies have identified recurrent oncogenic mutations in colorectal cancer (CRC), but there is limited CRC genomic data from the Chinese Han population. Whole-genome sequencing was performed on 10 primary CRC tumors and matched adjacent normal tissues from patients from the Han population in Shanghai, at an average of 27.8× and 27.9× coverage, respectively. In the 10 tumor samples, 32 significant somatic mutated genes were identified, 13 of which were also reported as CRC mutations in The Cancer Genome Atlas Network. All the mutated genes were enriched in functions associated with channel activity, which has rarely been reported in previous studies investigating CRC. Furthermore, 21 chromosomal rearrangements were detected and 4 rearrangements encoded predicted in-frame fusion proteins, including a fusion of phosphorylase kinase regulatory subunit b and NOTCH2 demonstrated in 2 out of 10 tumors. Chromosome 8 was amplified in 1 tumor and chromosome 20 was amplified in 2 out of 10 CRC patients. The present study produced a genomic mutation profile of CRC, which provides a valuable resource for further insight into the mutations that characterize CRC in patients from the Han population in Shanghai, eastern China.
- Published
- 2018
41. Association of Parkinson’s Disease With Microbes and Microbiological Therapy
- Author
-
Lei Cui, Zhao-Ji Chen, Si-Min Ren, Li-Qing Yang, Bu-Lang Gao, Yan-Min Xia, Xiao-Fang Li, and Cheng-Yu Liang
- Subjects
0301 basic medicine ,Microbiology (medical) ,Parkinson's disease ,Synbiotics ,Immunology ,Population ,Gut–brain axis ,microbiological therapy ,lcsh:QR1-502 ,Substantia nigra ,Review ,Catechol O-Methyltransferase ,Microbiology ,lcsh:Microbiology ,Levodopa ,03 medical and health sciences ,Cellular and Infection Microbiology ,0302 clinical medicine ,Flora (microbiology) ,Humans ,Medicine ,education ,education.field_of_study ,business.industry ,Lachnospiraceae ,Dopaminergic ,Parkinson Disease ,Fecal Microbiota Transplantation ,medicine.disease ,Gastrointestinal Microbiome ,microbe ,a-synuclein ,030104 developmental biology ,Infectious Diseases ,Parkinson’s disease ,pathology ,business ,030217 neurology & neurosurgery - Abstract
Parkinson’s disease (PD) is the most common movement disorder in the world, affecting 1–2 per 1,000 of the population. The main pathological changes of PD are damage of dopaminergic neurons in substantia nigra of the central nervous system and formation of Lewy bodies. These pathological changes also occur in the intestinal tract and are strongly associated with changes in intestinal flora. By reviewing the research progress in PD and its association with intestinal flora in recent years, this review expounded the mechanism of action between intestinal flora and PD as well as the transmission mode of α - synuclein in neurons. In clinical studies, β diversity of intestinal flora in PD patients was found to change significantly, with Lactobacillusaceae and Verrucomicrobiaceae being significantly increased and Lachnospiraceae and Prevotellaceae being significantly decreased. In addition, a longer PD course was associated with fewer bacteria and probiotics producing short chain fatty acids, but more pathogenic bacteria. Moreover, the motor symptoms of PD patients may be related to Enterobacteriaceae and bacteria. Most importantly, catechol-O-methyltransferase inhibitors and anticholinergic drugs could change the intestinal flora of PD patients and increase the harmful flora, whereas other anti-PD drugs such as levodopa, dopamine agonist, monoamine oxidase inhibitors, and amantadine did not have these effects. Probiotics, prebiotics, and synbiotics treatment had some potential values in improving the constipation of PD patients, promoting the growth of probiotics, and improving the level of intestinal inflammation. At present, there were only a few case studies and small sample studies which have found certain clinical efficacy of fecal microbiome transplants. Further studies are necessary to elaborate the relationship of PD with microbes.
- Published
- 2021
42. AKT1-CREB stimulation of PDGFRα expression is pivotal for PTEN deficient tumor development
- Author
-
Fuqiang Huang, Na Zhao, Min Ren, Xiaojun Zha, Fuquan Jin, Meng Zhou, Xiaofeng Wan, Zhongdong Hu, Wanhui Zhu, Yani Wang, Xianguo Chen, Hongbing Zhang, Xu Chen, Zhaofei Ni, and Yuncui Wu
- Subjects
Male ,0301 basic medicine ,Cancer Research ,Receptor, Platelet-Derived Growth Factor alpha ,AKT1 ,0302 clinical medicine ,Neoplasms ,Antineoplastic Combined Chemotherapy Protocols ,Conditional gene knockout ,Tumour-suppressor proteins ,Cyclic AMP Response Element-Binding Protein ,Mice, Knockout ,Mice, Inbred BALB C ,biology ,lcsh:Cytology ,Chemistry ,Gene Expression Regulation, Neoplastic ,Liver ,030220 oncology & carcinogenesis ,embryonic structures ,Quinolines ,Signal transduction ,Heterocyclic Compounds, 3-Ring ,Platelet-derived growth factor receptor ,Signal Transduction ,Immunology ,Mice, Nude ,CREB ,Article ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,Growth factor receptor ,Cell Line, Tumor ,medicine ,Animals ,Humans ,PTEN ,lcsh:QH573-671 ,Protein Kinase Inhibitors ,Cell Proliferation ,PTEN Phosphohydrolase ,Cancer ,Oncogenes ,Cell Biology ,Fibroblasts ,medicine.disease ,Xenograft Model Antitumor Assays ,HEK293 Cells ,030104 developmental biology ,biology.protein ,Cancer research ,Benzimidazoles ,Proto-Oncogene Proteins c-akt - Abstract
As evidenced by the behavior of loss-of-function mutants of PTEN in the context of a gain-of-function mutation of AKT1, the PTEN-AKT1 signaling pathway plays a critical role in human cancers. In this study, we demonstrated that a deficiency in PTEN or activation of AKT1 potentiated the expression of platelet-derived growth factor receptor α (PDGFRα) based on studies on Pten−/− mouse embryonic fibroblasts, human cancer cell lines, the hepatic tissues of Pten conditional knockout mice, and human cancer tissues. Loss of PTEN enhanced PDGFRα expression via activation of the AKT1-CREB signaling cascade. CREB transactivated PDGFRα expression by direct binding of the promoter of the PDGFRα gene. Depletion of PDGFRα attenuated the tumorigenicity of Pten-null cells in nude mice. Moreover, the PI3K-AKT signaling pathway has been shown to positively correlate with PDGFRα expression in multiple cancers. Augmented PDGFRα was associated with poor survival of cancer patients. Lastly, combination treatment with the AKT inhibitor MK-2206 and the PDGFR inhibitor CP-673451 displayed synergistic anti-tumor effects. Therefore, activation of the AKT1-CREB-PDGFRα signaling pathway contributes to the tumor growth induced by PTEN deficiency and should be targeted for cancer treatment.
- Published
- 2021
43. Application Experience and Patient Feedback Analysis of 3D Printed AFO with Different Materials: A Random Crossover Study
- Author
-
Zhenjing Li, Yan Zhuang, Linling Jiang, Xianzhong Meng, Yu Qu, and Min Ren
- Subjects
030506 rehabilitation ,medicine.medical_specialty ,3d printed ,Article Subject ,Computer science ,0206 medical engineering ,Foot Orthoses ,02 engineering and technology ,General Biochemistry, Genetics and Molecular Biology ,Feedback ,03 medical and health sciences ,Physical medicine and rehabilitation ,Materials Testing ,medicine ,Ankle dorsiflexion ,Humans ,Range of Motion, Articular ,Statistical processing ,Cross-Over Studies ,General Immunology and Microbiology ,Stroke Rehabilitation ,Surface smoothness ,General Medicine ,Equipment Design ,020601 biomedical engineering ,Crossover study ,Paresis ,Stroke ,Patient feedback ,Treatment Outcome ,Patient Satisfaction ,Printing, Three-Dimensional ,Medicine ,Ankle ,0305 other medical science ,Ankle Joint ,Research Article - Abstract
Purpose. This study is aimed at analyzing the application experience and feedback of the patients with poststroke ankle dorsiflexion disorders for 3D printed AFO with three different materials. Methods. 15 patients were randomly divided into three groups; 3D printed AFO with 3 different materials (PA2200, Somos NeXt, and PA12) was used to each group, according to the crossover study design, in order to ask the three groups of patients to use three different materials of 3D printed AFO. Assessment was taken by the end of each test round. Through statistical processing, the patient feedback data of the three groups of materials of 3D printed AFO were obtained. Results. In the material comfort assessment of the AFO, Somos NeXt was compared with PA2200, and the p value was p value was p value was
- Published
- 2021
44. Reconstituted high density lipoprotein (rHDL), a versatile drug delivery nanoplatform for tumor targeted therapy
- Author
-
Min Ren, Wei Wang, Yijun Mei, Qiaqia Xiao, Lu Tang, Ziqi Zhang, Jing Zang, Ying Wang, Jianping Zhou, and Ziyao Zhang
- Subjects
0303 health sciences ,Biocompatibility ,Chemistry ,Biomedical Engineering ,Tumor cells ,Antineoplastic Agents ,Biocompatible Materials ,02 engineering and technology ,General Chemistry ,General Medicine ,Pharmacology ,021001 nanoscience & nanotechnology ,Tumor targeted ,03 medical and health sciences ,Drug Delivery Systems ,In vivo ,Neoplasms ,Drug delivery ,Humans ,Nanoparticles ,General Materials Science ,0210 nano-technology ,Lipoproteins, HDL ,030304 developmental biology ,Cell Proliferation - Abstract
rHDL is a synthesized drug delivery nanoplatform exhibiting excellent biocompatibility, which possesses most of the advantages of HDL. rHDL shows almost no toxicity and can be degraded to non-toxic substances in vivo. The severe limitation of the application of various antitumor agents is mainly due to their low bioavailability, high toxicity, poor stability, etc. Favorably, antitumor drug-loaded rHDL nanoparticles (NPs), which are known as an important drug delivery system (DDS), help to change the situation a lot. This DDS shows an outstanding active-targeting ability towards tumor cells and improves the therapeutic effect during antitumor treatment while overcoming the shortcomings mentioned above. In the following text, we will mainly focus on the various applications of rHDL in tumor targeted therapy by describing the properties, preparation, receptor active-targeting ability and antitumor effects of antineoplastic drug-loaded rHDL NPs.
- Published
- 2020
45. A single‐center retrospective study of the clinical significance of chorionic bump at early stage of gestation
- Author
-
Yilun Wu, Yu Lu, Fan Huang, and Min Ren
- Subjects
Adult ,medicine.medical_specialty ,Immunology ,Gestational sac ,Gestational Age ,Ultrasonography, Prenatal ,Pregnancy ,medicine ,Humans ,Immunology and Allergy ,Childbirth ,Clinical significance ,Retrospective Studies ,Hematoma ,business.industry ,Obstetrics ,Pregnancy Outcome ,Obstetrics and Gynecology ,Gestational age ,Retrospective cohort study ,Arteries ,Chorion ,Middle Aged ,medicine.disease ,Pregnancy Complications ,medicine.anatomical_structure ,Reproductive Medicine ,Cohort ,Gestation ,Female ,business - Abstract
PROBLEM The chorionic bump is a distinct rare sonographic abnormality. Until now, there is contradictory evidence about if it associates with poor pregnancy outcomes. We performed this retrospective study to provide additional clinical data to investigate the clinical significance of chorionic bump at early stage of pregnancy. METHOD OF STUDY A single-center retrospective study was performed using the sonographic and clinical data of the pregnant women who had antenatal checkup and childbirth at Shanghai First Maternal and Child Health Care Center from December 2018 to December 2019. Sonographic examination was performed by experts at 5-10 weeks' gestation. Maternal age and gestational age matched controls from the same period were selected for analysis. RESULTS We observed 83 chorionic bump cases showing a prevalence of 0.33%. We found previous intrauterine operations and/or adverse maternal history posed a risk of having chorionic bump. In our cohort, chorionic bump associates with poor pregnancy outcomes. Poor pregnancy outcomes were more frequently found in the patients whose lesions were detected early (
- Published
- 2020
46. Binding and Activity of Tetrabromobisphenol A Mono-Ether Structural Analogs to Thyroid Hormone Transport Proteins and Receptors
- Author
-
Jianjie Fu, Aiqian Zhang, Jianbo Shi, Qinghua Zhang, Pu Wang, Guangbo Qu, Qiao Xue, Linlin Yao, Guibin Jiang, and Xiao-Min Ren
- Subjects
Thyroid Hormones ,Thyroxine-Binding Globulin ,Health, Toxicology and Mutagenesis ,Polybrominated Biphenyls ,Ether ,010501 environmental sciences ,01 natural sciences ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Humans ,030212 general & internal medicine ,Receptor ,0105 earth and related environmental sciences ,Thyroid hormone transport ,Flame Retardants ,Research ,Public Health, Environmental and Occupational Health ,Molecular Docking Simulation ,Transformation (genetics) ,chemistry ,Biochemistry ,Tetrabromobisphenol A ,Environmental Pollutants ,Carrier Proteins ,Ethers - Abstract
Background: Tetrabromobisphenol A (TBBPA) mono-ether structural analogs, identified as the by-products or transformation products of commercial TBBPA bis-ether derivatives, have been identified as emerging widespread pollutants. However, there is very little information regarding their toxicological effects. Objective: We aimed to explore the potential thyroid hormone (TH) system–disrupting effect of TBBPA mono-ether structural analogs. Methods: The binding potencies of chemicals toward human TH transport proteins [transthyretin (TTR) and thyroxine-binding globulin (TBG)] and receptors [TRα ligand-binding domain (LBD) and TRβ-LBD] were determined by fluorescence competitive binding assays. Molecular docking was used to simulate the binding modes of the chemicals with the proteins. The cellular TR-disrupting potencies of chemicals were assessed by a GH3 cell proliferation assay. The intracellular concentrations of the chemicals were measured by high-performance liquid chromatography and mass spectrometry. Results: TBBPA mono-ether structural analogs bound to TTR with half maximal inhibitory concentrations ranging from 0.1μM to 1.0μM but did not bind to TBG. They also bound to both subtypes of TR-LBDs with 20% maximal inhibitory concentrations ranging from 4.0μM to 50.0μM. The docking results showed that the analogs fit into the ligand-binding pockets of TTR and TR-LBDs with binding modes similar to that of TBBPA. These compounds likely induced GH3 cell proliferation via TR [with the lowest effective concentrations (LOECs) ranging from 0.3μM to 2.5μM] and further enhanced TH-induced GH3 cell proliferation (with LOECs ranging from 0.3μM to 1.2μM). Compared with TBBPA, TBBPA-mono(2,3-dibromopropyl ether) showed a 4.18-fold higher GH3 cell proliferation effect and 105-fold higher cell membrane transportation ability. Conclusion: This study provided a possible mechanism underlying the difference in TTR or TR binding by novel TBBPA structural analogs. These compounds might exert TH system–disrupting effects by disrupting TH transport in circulation and TR activity in TH-responsive cells. https://doi.org/10.1289/EHP6498
- Published
- 2020
47. Diagnostic significance of long non-coding RNAs expression in tuberculosis patients
- Author
-
Xiaoling, Zhong, Qin, Guo, Jing, Zhao, Yinyue, Li, Xue, Li, Min, Ren, and Min, Shu
- Subjects
ROC Curve ,Odds Ratio ,Humans ,Tuberculosis ,RNA, Long Noncoding ,General Medicine ,Biomarkers - Abstract
It is crucial to identify effective diagnostic biosignatures of tuberculosis (TB) to optimize its treatment. Herein, we conducted a systematic review to elucidate the diagnostic efficacy of long noncoding RNA (lncRNAs) as TB biomarkers.We searched Medline, Web of Science, Embase, Cochrane Library, CNKI, Wanfang, VIP, and China Biology Medicine disc databases up to February 18, 2020. These studies focusing on lncRNAs as diagnosis markers of TB were collected. STATA 12.0 and Meta-disc1.4 software were used to analyze the data extracted from eligible studies.We included 8 articles with 1058 TB patients, and 1896 healthy controls in our study. The values of pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio were 0.63, 0.86, 4.48, 0.43, and 10.31, respectively. Additionally, we plotted the summary receiver operating characteristic curve to evaluate the diagnostic accuracy, and the area under the curve was 0.80.The present study is the first meta-analysis to assess the diagnostic accuracy of lncRNAs in TB patients. We found that lncRNAs might constitute potential biomarkers for the diagnosis of TB patients. More population-based high-quality research should be conducted to validate the efficacy lncRNAs in TB patients.
- Published
- 2022
48. The value of the neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio as complementary diagnostic tools in the diagnosis of rheumatoid arthritis: A multicenter retrospective study
- Author
-
Min Ren, Lin Zhuang, Shuang Yao, Ping Zhang, Qiang Wang, Zihan Jin, Xiaolong Yu, Xiaohong Li, and Gaojun Cai
- Subjects
rheumatoid arthritis ,Male ,0301 basic medicine ,Neutrophils ,Clinical Biochemistry ,Youden's J statistic ,Gastroenterology ,Arthritis, Rheumatoid ,0302 clinical medicine ,platelet‐to‐lymphocyte ratio ,Immunology and Allergy ,Lymphocytes ,Research Articles ,medicine.diagnostic_test ,Area under the curve ,Complete blood count ,Hematology ,Middle Aged ,neutrophil‐to‐lymphocyte ratio ,Medical Laboratory Technology ,Area Under Curve ,030220 oncology & carcinogenesis ,Erythrocyte sedimentation rate ,Rheumatoid arthritis ,Female ,complementary diagnostic tools ,Research Article ,Blood Platelets ,Microbiology (medical) ,medicine.medical_specialty ,03 medical and health sciences ,Internal medicine ,medicine ,Humans ,Rheumatoid factor ,Lymphocyte Count ,Neutrophil to lymphocyte ratio ,Aged ,Retrospective Studies ,Receiver operating characteristic ,Platelet Count ,business.industry ,fungi ,Biochemistry (medical) ,Public Health, Environmental and Occupational Health ,medicine.disease ,body regions ,030104 developmental biology ,ROC Curve ,business ,Biomarkers - Abstract
Background The neutrophil‐to‐lymphocyte ratio (NLR) and platelet‐to‐lymphocyte ratio (PLR) have drawn attention in recent years as novel non‐specific inflammatory markers; however, only a few studies have been conducted to investigate their value in RA. Objective To investigate the value of the neutrophil‐to‐lymphocyte ratio (NLR) and the platelet‐to‐lymphocyte ratio (PLR) as complementary diagnostic tools in rheumatoid arthritis (RA). Method This study included 1009 patients with RA, 170 patients with other rheumatic diseases, and 245 healthy individuals from four medical centers. The patients' general data, including complete blood count, C‐reactive protein (CRP), erythrocyte sedimentation rate (ESR), and rheumatoid factor (RF), were retrospectively analyzed, and the NLR and PLR were calculated. Potential effective indicators were screened by logistic regression analysis, and a receiver operating characteristic (ROC) curve was plotted to evaluate their diagnostic value for RA. Results (a) The NLR and PLR were significantly higher in the RA group than in the non‐RA group and the control group (P .05). The PLR was positively correlated with RF (r = .139, P, The ROC curve of the diagnostic value of the NLR for RA. At the cutoff value of 2.13 and an AUC of 0.831, the diagnostic sensitivity, specificity, and accuracy were 76.7%, 75.9%, and 76.4%, respectively, which were lower than the corresponding values for RF and CRP but higher than those for ESR. RF: rheumatoid factor; CRP: C‐reactive protein; ESR: erythrocyte sedimentation rate; NLR: neutrophil‐to‐lymphocyte ratio; Pre‐1: predicted probability‐1.
- Published
- 2020
49. Chemical Structure-Related Adipogenic Effects of Tetrabromobisphenol A and Its Analogues on 3T3-L1 Preadipocytes
- Author
-
Aifeng Liu, Jianqing Zhang, Qian S. Liu, Zhendong Sun, Qunfang Zhou, Zhihua Ren, Xiao-Min Ren, and Guibin Jiang
- Subjects
chemistry.chemical_classification ,Adipogenesis ,Polybrominated Biphenyls ,Peroxisome proliferator-activated receptor ,3T3-L1 ,General Chemistry ,010501 environmental sciences ,01 natural sciences ,PPAR gamma ,Transactivation ,chemistry.chemical_compound ,Mice ,Glucocorticoid receptor ,Nuclear receptor ,Biochemistry ,chemistry ,3T3-L1 Cells ,Brominated flame retardant ,Environmental Chemistry ,Tetrabromobisphenol A ,Animals ,Humans ,0105 earth and related environmental sciences ,Flame Retardants - Abstract
Tetrabromobisphenol A (TBBPA), the most widely used brominated flame retardant, is reported to potentially possess risks in inducing obesity or obesity-related metabolic diseases. Considering the increasing environmental contamination of TBBPA analogues and their high structural similarities to the parent compound, whether they could influence adipogenesis or not remains to be elucidated. In this study, two of the most prevalent TBBPA derivatives [i.e., TBBPA bis(allyl ether) (TBBPA-BAE) and TBBPA bis(2,3-dibromopropyl ether) (TBBPA-BDBPE)] and their byproducts [i.e., TBBPA mono(allyl ether) (TBBPA-MAE) and TBBPA mono(2,3-dibromopropyl ether) (TBBPA-MDBPE)], together with TBBPA, were screened for their capacities in activating peroxisome proliferator-activated receptor-γ (PPARγ) and glucocorticoid receptor (GR), the key nuclear receptors involved in adipogenesis, and their structure-related effects on differentiation of 3T3-L1 preadipocytes were explored. The results indicated that the binding affinities of TBBPA and its analogues for the PPARγ ligand-binding domain (PPARγ-LBD) and GR, as well as their effects on PPARγ transactivation, followed the order of TBBPA > TBBPA-MAE > TBBPA-MDBPE > TBBPA-BAE, TBBPA-BDBPE. Nevertheless, TBBPA-MAE and TBBPA-MDBPE showed higher potentials in promoting adipogenesis in 3T3-L1 cells than did TBBPA, as evidenced by intracellular triglyceride contents and adipogenic biomarkers at both protein and transcriptional levels. The etherified group at position 4 of TBBPA phenolic rings was crucial in chemical-induced adipogenic effects, which was related with the recruitment of PPARγ and GR-mediated networks and some other unidentified signaling pathways. The findings on the disturbance of TBBPA analogues on adipogenesis revealed their potential risk in causing obesity and other lipid metabolism-related human health concerns.
- Published
- 2020
50. [Effect of transcutaneous electrical acupoint stimulation on postoperative olfactory memory disorder and plasma melatonin in patients with general anesthesia of sevoflurane]
- Author
-
Jian, Huang, Hong, Gao, Ying, Cao, Jing, Zhou, Yi-Min, Ren, Te, Xi, Hua-Lin, Gao, An-Qi, Wang, and Wei, Zhou
- Subjects
Smell ,Olfaction Disorders ,Sevoflurane ,Transcutaneous Electric Nerve Stimulation ,Humans ,Anesthesia, General ,Acupuncture Points ,Melatonin - Abstract
To observe the effect of transcutaneous electrical acupoint stimulation (TEAS) on postoperative olfactory memory disorder in patients with general anesthesia of sevoflurane and to explore its possible mechanism.Forty patients who were scheduled to have gynecological and urological procedures under general anesthesia were randomly divided into an observation group and a control group, 20 cases in each group. The patients in the observation group were treated with TEAS (dilatational wave, 2 Hz/100 Hz) at Yingxiang (LI 20) and Yintang (GV 29) 10 min before anesthesia induction until the end of operation; the patients in the control group received general anesthesia directly. The changes of mean arterial pressure (MAP), heart rate (HR) and blood oxygen saturation (SpOThe between-group differences and within-group differences of MAP, HR and SpOTEAS could improve the postoperative olfactory memory disorder in patients with general anesthesia of sevoflurane, and its mechanism may be related to the increase of plasma concentration of melatonin.
- Published
- 2020
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.